CATH Search:   
       by CATH code, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: Alpha Beta (26913)
(-)
Architecture: 2-Layer Sandwich (8480)
(-)
Topology: Phosphorylase Kinase; domain 1 (1392)
(-)
Homologous Superfamily: Phosphorylase Kinase; domain 1 (1392)
(-)
Human (Homo sapiens) (1036)
1A9UA:5-110,A:320-349THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB203580
1AD5A:259-344; B:259-344SRC FAMILY KINASE HCK-AMP-PNP COMPLEX
1AGWB:465-563; A:465-563CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU4984 INHIBITOR
1AQ1A:1-84HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR STAUROSPORINE
1B38A:1-84HUMAN CYCLIN-DEPENDENT KINASE 2
1B39A:1-84HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160
1B6CB:175-284; D:175-284; F:175-284; H:175-284CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12
1BI7A:11-102MECHANISM OF G1 CYCLIN DEPENDENT KINASE INHIBITION FROM THE STRUCTURE OF THE CDK6-P16INK4A TUMOR SUPPRESSOR COMPLEX
1BI8A:11-102; C:11-102MECHANISM OF G1 CYCLIN DEPENDENT KINASE INHIBITION FROM THE STRUCTURES CDK6-P19INK4D INHIBITOR COMPLEX
1BL6A:5-110,A:320-349THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995
1BL7A:5-110,A:320-349THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB220025
1BLXA:11-102P19INK4D/CDK6 COMPLEX
1BMKA:5-110,A:320-349THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB218655
1BUHA:1-84CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITH CELL CYCLE-REGULATORY PROTEIN CKSHS1
1BYGA:187-268KINASE DOMAIN OF HUMAN C-TERMINAL SRC KINASE (CSK) IN COMPLEX WITH INHIBITOR STAUROSPORINE
1CKPA:1-84HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR PURVALANOL B
1CM8A:24-113; B:1024-1113PHOSPHORYLATED MAP KINASE P38-GAMMA
1DI8A:1-84THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[3-HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE
1DI9A:18-110THE STRUCTURE OF P38 MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH 4-[3-METHYLSULFANYLANILINO]-6,7-DIMETHOXYQUINAZOLINE
1DM2A:1-84HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR HYMENIALDISINE
1E1VA:1-84HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058
1E1XA:1-84HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027
1E9HC:1-84; A:1-84THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5-SULPHONATE BOUND
1F3MC:249-346; D:249-346CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE PAK1
1F5QA:1-84; C:1-84CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO HUMAN CYCLIN DEPENDENT KINASE 2
1FGIA:465-563; B:465-563CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH SU5402 INHIBITOR
1FINA:1-84; C:1-84CYCLIN A-CYCLIN-DEPENDENT KINASE 2 COMPLEX
1FMKA:259-344CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC
1FQ1B:1-84CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) IN COMPLEX WITH PHOSPHO-CDK2
1FVRA:813-904; B:813-904TIE2 KINASE DOMAIN
1FVTA:1-84THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH AN OXINDOLE INHIBITOR
1FVVA:1-84; C:1-84THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLE INHIBITOR
1G3NA:11-102; E:11-102STRUCTURE OF A P18(INK4C)-CDK6-K-CYCLIN TERNARY COMPLEX
1G5SA:1-84CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH THE INHIBITOR H717
1GAGA:984-1078CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITOR
1GIHA:1-84HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR
1GIIA:1-84HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR
1GIJA:1-84HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR
1GJOA:468-566THE FGFR2 TYROSINE KINASE DOMAIN
1GNGA:53-136; B:53-136GLYCOGEN SYNTHASE KINASE-3 BETA (GSK3) COMPLEX WITH FRATTIDE PEPTIDE
1GZ8A:1-84HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2-AMINO-6-(3'-METHYL-2'-OXO)BUTOXYPURINE
1GZKA:146-235,A:430-439MOLECULAR MECHANISM FOR THE REGULATION OF PROTEIN KINASE B/ AKT BY HYDROPHOBIC MOTIF PHOSPHORYLATION
1GZNA:146-235,A:430-439STRUCTURE OF PKB KINASE DOMAIN
1GZOA:146-235,A:430-439STRUCTURE OF PROTEIN KINASE B UNPHOSPHORYLATED
1H00A:1-84CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
1H01A:1-84CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
1H07A:1-84CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
1H08A:1-84CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
1H0VA:1-84HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[(R)-PYRROLIDINO-5'-YL]METHOXYPURINE
1H0WA:1-84HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[CYCLOHEX-3-ENYL]METHOXYPURINE
1H1PA:1-84; C:1-84STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058
1H1QA:1-84; C:1-84STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094
1H1RA:1-84; C:1-84STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086
1H1SA:1-84; C:1-84STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102
1H1WA:72-165HIGH RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN PDK1 CATALYTIC DOMAIN
1H24A:1-84; C:1-84CDK2/CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F
1H25A:1-84; C:1-84CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM RETINOBLASTOMA-ASSOCIATED PROTEIN
1H26A:1-84; C:1-84CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53
1H27A:1-84; C:1-84CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27
1H28A:1-84; C:1-84CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107
1H4LA:2-84; B:2-84STRUCTURE AND REGULATION OF THE CDK5-P25(NCK5A) COMPLEX
1H8FA:53-136; B:53-136GLYCOGEN SYNTHASE KINASE 3 BETA.
1HCKA:1-84HUMAN CYCLIN-DEPENDENT KINASE 2
1HCLA:1-84HUMAN CYCLIN-DEPENDENT KINASE 2
1I09B:38-136; A:55-136STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 (GSK3B)
1I44A:986-1078CRYSTALLOGRAPHIC STUDIES OF AN ACTIVATION LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE
1IA8A:2-97THE 1.7 A CRYSTAL STRUCTURE OF HUMAN CELL CYCLE CHECKPOINT KINASE CHK1
1IASA:171-284; B:171-284; C:171-284; D:171-284; E:171-284CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12
1IG1A:15-1051.8A X-RAY STRUCTURE OF TERNARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE AND MN.
1IR3A:984-1078PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH PEPTIDE SUBSTRATE AND ATP ANALOG
1IRKA:981-1078CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HUMAN INSULIN RECEPTOR
1J1BA:53-136; B:555-636BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH AMPPNP
1J1CA:53-136; B:555-636BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITH ADP
1JKKA:8-982.4A X-RAY STRUCTURE OF TERNARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE AND MG.
1JKLA:15-1051.6A X-RAY STRUCTURE OF BINARY COMPLEX OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE WITH ATP ANALOGUE
1JKSA:8-981.5A X-RAY STRUCTURE OF APO FORM OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE
1JKTA:8-98; B:8-98TETRAGONAL CRYSTAL FORM OF A CATALYTIC DOMAIN OF DEATH-ASSOCIATED PROTEIN KINASE
1JNKA:48-150THE C-JUN N-TERMINAL KINASE (JNK3S) COMPLEXED WITH MGAMP-PNP
1JQHA:984-1078; B:984-1078; C:984-1078IGF-1 RECEPTOR KINASE DOMAIN
1JSTA:1-84; C:1-84PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A
1JSUA:13-84P27(KIP1)/CYCLIN A/CDK2 COMPLEX
1JSVA:1-84THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[(6-AMINO-4-PYRIMIDINYL) AMINO]BENZENESULFONAMIDE
1JVPP:1-86CRYSTAL STRUCTURE OF HUMAN CDK2 (UNPHOSPHORYLATED) IN COMPLEX WITH PKF049-365
1JWHA:25-115; B:25-115CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2 HOLOENZYME
1K2PA:397-476; B:397-476CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE DOMAIN
1K3AA:958-1051STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR KINASE
1KE5A:1-84CDK2 COMPLEXED WITH N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE
1KE6A:1-84CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE
1KE7A:1-84CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE
1KE8A:1-84CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE
1KE9A:1-84CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({[AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE
1KSWA:259-344STRUCTURE OF HUMAN C-SRC TYROSINE KINASE (THR338GLY MUTANT) IN COMPLEX WITH N6-BENZYL ADP
1KV1A:5-110,A:320-351P38 MAP KINASE IN COMPLEX WITH INHIBITOR 1
1KV2A:5-110,A:320-351HUMAN P38 MAP KINASE IN COMPLEX WITH BIRB 796
1KWPA:59-140; B:59-140CRYSTAL STRUCTURE OF MAPKAP2
1M14A:673-768TYROSINE KINASE DOMAIN FROM EPIDERMAL GROWTH FACTOR RECEPTOR
1M17A:673-768EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE DOMAIN WITH 4-ANILINOQUINAZOLINE INHIBITOR ERLOTINIB
1M7NA:985-1078; B:985-1078CRYSTAL STRUCTURE OF UNACTIVATED APO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE DOMAIN
1M7QA:5-110,A:320-349CRYSTAL STRUCTURE OF P38 MAP KINASE IN COMPLEX WITH A DIHYDROQUINAZOLINONE INHIBITOR
1MP8A:414-501CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE (FAK)
1MQ4A:128-216CRYSTAL STRUCTURE OF AURORA-A PROTEIN KINASE
1MQBB:602-694; A:605-694CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINASE
1MRVA:147-235,A:430-438CRYSTAL STRUCTURE OF AN INACTIVE AKT2 KINASE DOMAIN
1MRYA:146-235,A:430-438CRYSTAL STRUCTURE OF AN INACTIVE AKT2 KINASE DOMAIN
1MUOA:128-216CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE-THREONINE KINASE
1NA7A:25-115CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2
1NVQA:3-97THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/UCN-01
1NVRA:3-97THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/STAUROSPORINE
1NVSA:3-97THE COMPLEX STRUCTURE OF CHECKPOINT KINASE CHK1/SB218078
1NXKA:59-140; B:59-140; C:59-140; D:59-140CRYSTAL STRUCTURE OF STAUROSPORINE BOUND TO MAP KAP KINASE 2
1NY3A:59-140CRYSTAL STRUCTURE OF ADP BOUND TO MAP KAP KINASE 2
1O6KA:146-235,A:430-473STRUCTURE OF ACTIVATED FORM OF PKB KINASE DOMAIN S474D WITH GSK3 PEPTIDE AND AMP-PNP
1O6LA:146-235,A:430-473CRYSTAL STRUCTURE OF AN ACTIVATED AKT/PROTEIN KINASE B (PKB-PIF CHIMERA) TERNARY COMPLEX WITH AMP-PNP AND GSK3 PEPTIDE
1O9UA:53-136GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE
1OECA:468-566FGFR2 KINASE DOMAIN
1OGUC:1-84; A:1-84STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4-CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR
1OI9C:1-84; A:1-84STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
1OIQA:1-84IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION
1OIRA:1-84IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION
1OITA:3-84IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION
1OIUC:1-84; A:1-84STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
1OIYC:1-84; A:1-84STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
1OKVA:1-84; C:1-84CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ILE-PHE-NH2
1OKWA:1-84; C:1-84CYCLIN A BINDING GROOVE INHIBITOR AC-ARG-ARG-LEU-ASN-(M-CL-PHE)-NH2
1OKYA:72-165STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
1OKZA:73-165STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH UCN-01
1OL1A:1-84; C:1-84CYCLIN A BINDING GROOVE INHIBITOR H-CIT-CIT-LEU-ILE-(P-F-PHE)-NH2
1OL2A:1-84; C:1-84CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ASN-(P-F-PHE)-NH2
1OL5A:128-216STRUCTURE OF AURORA-A 122-403, PHOSPHORYLATED ON THR287, THR288 AND BOUND TO TPX2 1-43
1OL6A:128-216STRUCTURE OF UNPHOSPHORYLATED D274N MUTANT OF AURORA-A
1OL7A:128-216STRUCTURE OF HUMAN AURORA-A 122-403 PHOSPHORYLATED ON THR287, THR288
1OPLB:253-336; A:259-344STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE KINASE
1OUKA:5-110,A:320-349THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A PYRIDINYLIMIDAZOLE INHIBITOR
1OUYA:5-110,A:320-349THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A DIHYDROPYRIDO-PYRIMIDINE INHIBITOR
1OVEA:5-110,A:320-349THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A DIHYDROQUINOLINONE
1OZ1A:5-110,A:320-349P38 MITOGEN-ACTIVATED KINASE IN COMPLEX WITH 4-AZAINDOLE INHIBITOR
1P14A:981-1078CRYSTAL STRUCTURE OF A CATALYTIC-LOOP MUTANT OF THE INSULIN RECEPTOR TYROSINE KINASE
1P2AA:1-84THE STRUCTURE OF CYCLIN DEPENDENT KINASE 2 (CKD2) WITH A TRISUBSTITUTED NAPHTHOSTYRIL INHIBITOR
1P4FA:8-98DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN WITH BOUND INHIBITOR FRAGMENT
1P4OA:948-1050; B:948-1050STRUCTURE OF APO UNACTIVATED IGF-1R KINASE DOMAIN AT 1.5A RESOLUTION.
1P5EA:1-84; C:1-84THE STRUCTURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR 4,5,6,7-TETRABROMOBENZOTRIAZOLE (TBS)
1PF8A:1-84CRYSTAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH A NUCLEOSIDE INHIBITOR
1PJKA:25-115CRYSTAL STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT
1PKDA:1-84; C:1-84THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO-CDK2/CYCLIN A
1PKGA:577-672; B:576-672STRUCTURE OF A C-KIT KINASE PRODUCT COMPLEX
1PMEA:16-107,A:339-356STRUCTURE OF PENTA MUTANT HUMAN ERK2 MAP KINASE COMPLEXED WITH A SPECIFIC INHIBITOR OF HUMAN P38 MAP KINASE
1PMNA:48-150CRYSTAL STRUCTURE OF JNK3 IN COMPLEX WITH AN IMIDAZOLE-PYRIMIDINE INHIBITOR
1PMQ  [entry was replaced by entry 4Z9L without any CATH domain information]
1PMUA:48-150THE CRYSTAL STRUCTURE OF JNK3 IN COMPLEX WITH A PHENANTROLINE INHIBITOR
1PMVA:48-150THE STRUCTURE OF JNK3 IN COMPLEX WITH A DIHYDROANTHRAPYRAZOLE INHIBITOR
1PW2A:1-84APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2
1PXIA:1-84HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,5-DICHLORO-THIOPHEN-3-YL)-PYRIMIDIN-2-YLAMINE
1PXJA:1-84HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINE
1PXKA:1-84HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)PYRIMIDIN-2-YL]-N'-HYDROXYIMINOFORMAMIDE
1PXLA:1-84HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(4-TRIFLUOROMETHYL-PHENYL)-AMINE
1PXMA:1-84HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 3-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINO]-PHENOL
1PXNA:1-84HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-[4-(4-METHYL-2-METHYLAMINO-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINO]-PHENOL
1PXOA:1-84HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2-AMINO-4-METHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(3-NITRO-PHENYL)-AMINE
1PXPA:1-84HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE
1PY5A:200-284CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH INHIBITOR
1PYEA:1-84CRYSTAL STRUCTURE OF CDK2 WITH INHIBITOR
1PYXA:40-136; B:53-136GSK-3 BETA COMPLEXED WITH AMP-PNP
1Q3DB:53-136; A:53-136GSK-3 BETA COMPLEXED WITH STAUROSPORINE
1Q3WA:38-136; B:38-136GSK-3 BETA COMPLEXED WITH ALSTERPAULLONE
1Q41A:38-136; B:53-136GSK-3 BETA COMPLEXED WITH INDIRUBIN-3'-MONOXIME
1Q4LA:53-136; B:53-136GSK-3 BETA COMPLEXED WITH INHIBITOR I-5
1Q5KA:40-136; B:53-136CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 IN COMPLEXED WITH INHIBITOR
1QCFA:259-344CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH A SRC FAMILY-SELECTIVE TYROSINE KINASE INHIBITOR
1QMZA:1-84; C:1-84PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX
1QPCA:231-318STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
1QPDA:231-318STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
1QPEA:231-318STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAMILY SELECTIVE KINASE INHIBITORS
1QPJA:236-318CRYSTAL STRUCTURE OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH STAUROSPORINE.
1R0EA:53-136; B:53-136GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH 3-INDOLYL-4-ARYLMALEIMIDE INHIBITOR
1R0PA:1061-1159CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH THE MICROBIAL ALKALOID K-252A
1R1WA:1061-1159CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET
1R39A:5-110,A:320-349THE STRUCTURE OF P38ALPHA
1R3CA:5-110,A:320-349THE STRUCTURE OF P38ALPHA C162S MUTANT
1R78A:1-84CDK2 COMPLEX WITH A 4-ALKYNYL OXINDOLE INHIBITOR
1RJBA:572-695CRYSTAL STRUCTURE OF FLT3
1RQQA:987-1078; B:987-1078CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH THE SH2 DOMAIN OF APS
1RW8A:200-284CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH ATP SITE INHIBITOR
1S9IB:59-151; A:60-151X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2 (MEK2)IN A COMPLEX WITH LIGAND AND MGATP
1S9JA:61-146X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
1SM2A:357-439; B:358-439CRYSTAL STRUCTURE OF THE PHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
1SNUA:357-439; B:358-439CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
1SNXA:357-439; B:357-439CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN
1T45A:547-672STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE
1T46A:577-672STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE
1TKIA:18-101; B:18-101AUTOINHIBITED SERINE KINASE DOMAIN OF THE GIANT MUSCLE PROTEIN TITIN
1TVOA:8-107,A:337-357THE STRUCTURE OF ERK2 IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
1U46A:117-207; B:117-207CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED KINASE DOMAIN OF THE TYROSINE KINASE ACK1
1U4DA:117-207; B:117-207STRUCTURE OF THE ACK1 KINASE DOMAIN BOUND TO DEBROMOHYMENIALDISINE
1U54A:115-207; B:117-207CRYSTAL STRUCTURES OF THE PHOSPHORYLATED AND UNPHOSPHORYLATED KINASE DOMAINS OF THE CDC42-ASSOCIATED TYROSINE KINASE ACK1 BOUND TO AMP-PCP
1U59A:328-416CRYSTAL STRUCTURE OF THE ZAP-70 KINASE DOMAIN IN COMPLEX WITH STAUROSPORINE
1UA2A:13-95; B:13-95; C:13-95; D:13-95CRYSTAL STRUCTURE OF HUMAN CDK7
1UKHA:10-112STRUCTURAL BASIS FOR THE SELECTIVE INHIBITION OF JNK1 BY THE SCAFFOLDING PROTEIN JIP1 AND SP600125
1UKIA:10-112STRUCTURAL BASIS FOR THE SELECTIVE INHIBITION OF JNK1 BY THE SCAFFOLDING PROTEIN JIP1 AND SP600125
1UNGA:1-84; B:2-84STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE, ALOISINE AND INDIRUBIN.
1UNHA:2-84; B:2-84STRUCTURAL MECHANISM FOR THE INHIBITION OF CDK5-P25 BY ROSCOVITINE, ALOISINE AND INDIRUBIN.
1UNLA:1-84; B:1-84STRUCTURAL MECHANISM FOR THE INHIBITION OF CD5-P25 FROM THE ROSCOVITINE, ALOISINE AND INDIRUBIN.
1URCA:1-84; C:1-84CYCLIN A BINDING GROOVE INHIBITOR ACE-ARG-LYS-LEU-PHE-GLY
1URWA:1-84CDK2 IN COMPLEX WITH AN IMIDAZO[1,2-B]PYRIDAZINE
1UU3A:73-165STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH LY333531
1UU7A:73-165STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-2
1UU8A:72-165STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-1
1UV5A:53-136GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 6-BROMOINDIRUBIN-3'-OXIME
1UVRA:72-165STRUCTURE OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH BIM-8
1UWHA:447-532; B:447-532THE COMPLEX OF WILD TYPE B-RAF AND BAY439006
1UWJA:447-532; B:447-532THE COMPLEX OF MUTANT V599E B-RAF AND BAY439006
1V1KA:1-84CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
1VJYA:201-284CRYSTAL STRUCTURE OF A NAPHTHYRIDINE INHIBITOR OF HUMAN TGF-BETA TYPE I RECEPTOR
1VR2A:820-918HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN
1VYWA:1-84; C:1-84STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137
1VYZA:1-84STRUCTURE OF CDK2 COMPLEXED WITH PNU-181227
1VZOA:24-134THE STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF MSK1 REVEALS A NOVEL AUTOINHIBITORY CONFORMATION FOR A DUAL KINASE PROTEIN
1W7HA:18-110P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1W82A:18-110P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1W83A:18-110P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1W84A:18-110P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
1W8CA:1-84CO-CRYSTAL STRUCTURE OF 6-CYCLOHEXYLMETHOXY-8-ISOPROPYL-9H-PURIN-2-YLAMINE AND MONOMERIC CDK2
1W98A:0-84THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E
1WAKA:63-133,A:145-167X-RAY STRUCTURE OF SRPK1
1WBNA:18-110FRAGMENT BASED P38 INHIBITORS
1WBOA:18-110FRAGMENT BASED P38 INHIBITORS
1WBPA:67-133,A:145-167SRPK1 BOUND TO 9MER DOCKING MOTIF PEPTIDE
1WBSA:18-110IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
1WBTA:18-110IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
1WBVA:18-110IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
1WBWA:18-110IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION.
1WCCA:1-84SCREENING FOR FRAGMENT BINDING BY X-RAY CRYSTALLOGRAPHY
1WFCA:5-110,A:320-351STRUCTURE OF APO, UNPHOSPHORYLATED, P38 MITOGEN ACTIVATED PROTEIN KINASE P38 (P38 MAP KINASE) THE MAMMALIAN HOMOLOGUE OF THE YEAST HOG1 PROTEIN
1WMKC:2-97; F:2-97; A:2-98; B:9-95; D:9-95; E:9-95; G:9-95; H:9-95HUMAN DEATH-ASSOCIATED KINASE DRP-1, MUTANT S308D D40
1WVWA:8-98CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
1WVXA:8-98CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
1WVYA:8-98CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS
1WZYA:8-107,A:337-357CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A PYRAZOLOPYRIDAZINE DERIVATIVE
1X8BA:291-355,A:361-379STRUCTURE OF HUMAN WEE1A KINASE: KINASE DOMAIN COMPLEXED WITH INHIBITOR PD0407824
1XBAA:363-450CRYSTAL STRUCTURE OF APO SYK TYROSINE KINASE DOMAIN
1XBBA:363-450CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH GLEEVEC
1XBCA:363-450CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH STAUROSPORIN
1XJDA:377-464CRYSTAL STRUCTURE OF PKC-THETA COMPLEXED WITH STAUROSPORINE AT 2A RESOLUTION
1XKKA:702-792EGFR KINASE DOMAIN COMPLEXED WITH A QUINAZOLINE INHIBITOR-GW572016
1XQZA:32-124CRYSTAL STRUCTURE OF HPIM-1 KINASE AT 2.1 A RESOLUTION
1XR1A:32-124CRYSTAL STRUCTURE OF HPIM-1 KINASE IN COMPLEX WITH AMP-PNP AT 2.1 A RESOLUTION
1XWSA:33-124CRYSTAL STRUCTURE OF THE HUMAN PIM1 KINASE DOMAIN
1Y57A:259-344STRUCTURE OF UNPHOSPHORYLATED C-SRC IN COMPLEX WITH AN INHIBITOR
1Y6AA:818-916CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR
1Y6BA:817-916CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR
1Y8YA:1-84CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1, 5-A]PYRIMIDINE INHIBITOR
1Y91A:1-84CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1, 5-A]PYRIMIDINE INHIBITOR
1YHSA:33-124CRYSTAL STRUCTURE OF PIM-1 BOUND TO STAUROSPORINE
1YHVA:249-346CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH TWO POINT MUTATIONS (K299R, T423E)
1YHWA:249-346CRYSTAL STRUCTURE OF PAK1 KINASE DOMAIN WITH ONE POINT MUTATIONS (K299R)
1YI3A:33-124CRYSTAL STRUCTURE OF PIM-1 BOUND TO LY294002
1YI4A:33-124STRUCTURE OF PIM-1 BOUND TO ADENOSINE
1YI6A:258-342; B:258-342C-TERM TAIL SEGMENT OF HUMAN TYROSINE KINASE (258-533)
1YKRA:1-84CRYSTAL STRUCTURE OF CDK2 WITH AN AMINOIMIDAZO PYRIDINE INHIBITOR
1YOJA:263-344; B:271-345CRYSTAL STRUCTURE OF SRC KINASE DOMAIN
1YOLA:258-342; B:261-342CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH CGP77675
1YOMA:257-342; B:257-342CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH PURVALANOL A
1YQJA:-3-110,A:320-349CRYSTAL STRUCTURE OF P38 ALPHA IN COMPLEX WITH A SELECTIVE PYRIDAZINE INHIBITOR
1YRPA:8-98; B:8-98CATALYTIC DOMAIN OF HUMAN ZIP KINASE PHOSPHORYLATED AT THR265
1YVJA:814-904CRYSTAL STRUCTURE OF THE JAK3 KINASE DOMAIN IN COMPLEX WITH A STAUROSPORINE ANALOGUE
1YWNA:818-916VEGFR2 IN COMPLEX WITH A NOVEL 4-AMINO-FURO[2,3-D]PYRIMIDINE
1YWVA:33-124CRYSTAL STRUCTURES OF PROTO-ONCOGENE KINASE PIM1: A TARGET OF ABERRANT SOMATIC HYPERMUTATIONS IN DIFFUSE LARGE CELL LYMPHOMA
1YXSA:33-124CRYSTAL STRUCTURE OF KINASE PIM1 WITH P123M MUTATION
1YXTA:33-124CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMPPNP
1YXUA:33-124; B:33-124; D:33-124; C:34-124CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMP
1YXVA:33-124CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH 3,4-DIHYDROXY-1-METHYLQUINOLIN-2(1H)-ONE
1YXXA:33-124CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH (3E)-3-[(4-HYDROXYPHENYL)IMINO]-1H-INDOL-2(3H)-ONE
1Z57A:-2-220,A:225-243CRYSTAL STRUCTURE OF HUMAN CLK1 IN COMPLEX WITH 10Z-HYMENIALDISINE
1Z5MA:74-165CRYSTAL STRUCTURE OF N1-[3-[[5-BROMO-2-[[3-[(1-PYRROLIDINYLCARBONYL) AMINO]PHENYL]AMINO]-4-PYRIMIDINYL]AMINO]PROPYL]-2,2-DIMETHYLPROPANEDIAMIDE COMPLEXED WITH HUMAN PDK1
1Z9XA:2-97; B:2-97; C:2-97HUMAN DRP-1 KINASE, W305S S308A D40 MUTANT, CRYSTAL FORM WITH 3 MONOMERS IN THE ASYMMETRIC UNIT
1ZLTA:2-97CRYSTAL STRUCTURE OF CHK1 COMPLEXED WITH A HYMENALDISINE ANALOG
1ZRZA:240-325,A:552-579CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ATYPICAL PROTEIN KINASE C-IOTA
1ZWSA:8-98; B:8-98; C:8-98; D:8-98; E:8-98; F:8-98; G:8-98; H:8-98CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE
1ZYJA:18-110HUMAN P38 MAP KINASE IN COMPLEX WITH INHIBITOR 1A
1ZYSA:3-97CO-CRYSTAL STRUCTURE OF CHECKPOINT KINASE CHK1 WITH A PYRROLO-PYRIDINE INHIBITOR
1ZZ2A:18-110TWO CLASSES OF P38ALPHA MAP KINASE INHIBITORS HAVING A COMMON DIPHENYLETHER CORE BUT EXHIBITING DIVERGENT BINDING MODES
1ZZLA:18-110CRYSTAL STRUCTURE OF P38 WITH TRIAZOLOPYRIDINE
2A0CX:1-84HUMAN CDK2 IN COMPLEX WITH OLOMOUCINE II, A NOVEL 2,6,9-TRISUBSTITUTED PURINE CYCLIN-DEPENDENT KINASE INHIBITOR
2A27B:2-97; C:2-97; E:2-97; F:2-97; G:2-97; A:9-95; D:9-95; H:9-95HUMAN DRP-1 KINASE, W305S S308A D40 MUTANT, CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT
2A2AB:2-97; C:2-97; D:2-97; A:1-97HIGH-RESOLUTION CRYSTALLOGRAPHIC ANALYSIS OF THE AUTOINHIBITED CONFORMATION OF A HUMAN DEATH-ASSOCIATED PROTEIN KINASE
2A4LA:1-84HUMAN CYCLIN-DEPENDENT KINASE 2 IN COMPLEX WITH ROSCOVITINE
2AC3A:82-161STRUCTURE OF HUMAN MNK2 KINASE DOMAIN
2AC5A:82-161STRUCTURE OF HUMAN MNK2 KINASE DOMAIN MUTANT D228G
2ACXA:179-269; B:179-269CRYSTAL STRUCTURE OF G PROTEIN COUPLED RECEPTOR KINASE 6 BOUND TO AMPPNP
2AUHA:984-1078CRYSTAL STRUCTURE OF THE GRB14 BPS REGION IN COMPLEX WITH THE INSULIN RECEPTOR TYROSINE KINASE
2AYPA:2-97CRYSTAL STRUCTURE OF CHK1 WITH AN INDOL INHIBITOR
2B1PA:48-150INHIBITOR COMPLEX OF JNK3
2B4SB:987-1078; D:987-1078CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THE INSULIN RECEPTOR TYROSINE KINASE
2B52A:1-84HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DPH-042562
2B53A:1-84HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DIN-234325
2B54A:1-84HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2)COMPLEXED WITH DIN-232305
2B55A:1-84HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH INDENOPYRAXOLE DIN-101312
2B7AB:840-931; A:843-931THE STRUCTURAL BASIS OF JANUS KINASE 2 INHIBITION BY A POTENT AND SPECIFIC PAN-JANUS KINASE INHIBITOR
2BAJA:-1-110,A:320-349P38ALPHA BOUND TO PYRAZOLOUREA
2BAKA:5-110,A:320-349P38ALPHA MAP KINASE BOUND TO MPAQ
2BALA:5-110,A:320-349P38ALPHA MAP KINASE BOUND TO PYRAZOLOAMINE
2BAQA:5-110,A:320-349P38ALPHA BOUND TO RO3201195
2BDFB:255-342; A:257-342SRC KINASE IN COMPLEX WITH INHIBITOR AP23451
2BDJA:257-342SRC KINASE IN COMPLEX WITH INHIBITOR AP23464
2BHEA:1-84HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 5-BROMO-INDIRUBINE
2BHHA:1-84HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 4-HYDROXYPIPERINDINESULFONYL-INDIRUBINE
2BIKB:33-124HUMAN PIM1 PHOSPHORYLATED ON SER261
2BILB:33-124THE HUMAN PROTEIN KINASE PIM1 IN COMPLEX WITH ITS CONSENSUS PEPTIDE PIMTIDE
2BIYA:72-165STRUCTURE OF PDK1-S241A MUTANT KINASE DOMAIN
2BKZA:1-84; C:1-84STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611
2BMCA:128-216; B:128-216; C:128-216; D:128-216; E:128-216; F:128-216AURORA-2 T287D T288D COMPLEXED WITH PHA-680632
2BPMA:1-84; C:1-84STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529
2BR1A:2-97STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRBA:2-97STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRGA:7-97STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRHA:6-97STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRMA:7-97STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BRNA:6-97STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BROA:2-97STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY
2BTRA:1-84STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873
2BTSA:1-84STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032
2BVAB:301-397; A:300-397CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4
2BZHB:32-124CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1
2BZIB:33-124CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU2
2BZJA:33-124CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU3
2C0IA:233-318; B:233-318SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983
2C0OA:233-318; B:233-318SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041
2C0TA:233-318; B:233-318SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-641359
2C30A:385-483CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 6
2C3JA:6-97IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION
2C3KA:6-97IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION
2C3LA:2-97IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION
2C47D:2-82; B:4-82; A:4-82; C:6-82STRUCTURE OF CASEIN KINASE 1 GAMMA 2
2C4GA:1-84; C:1-84STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514
2C5NA:1-84; C:1-84DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C5OA:1-84; C:1-84DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C5VA:1-84; C:1-84DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C5XA:1-84; C:1-84DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C5YA:1-84DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
2C68A:1-84CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C69A:1-84CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6DA:127-215AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH ADPNP
2C6EA:127-215; B:127-215AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH A 5-AMINOPYRIMIDINYL QUINAZOLINE INHIBITOR
2C6IA:1-84CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6KA:1-84CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6LA:1-84CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6MA:1-84CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6OA:1-84CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2C6TA:1-84; C:1-84CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
2CCHA:0-84; C:0-84THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE
2CCIA:0-84; C:0-84CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6
2CDZA:299-397CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4 IN COMPLEX WITH CGP74514A
2CGUA:6-97IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
2CGVA:6-97IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
2CGWA:6-97IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
2CGXA:6-97IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING
2CHLA:25-108STRUCTURE OF CASEIN KINASE 1 GAMMA 3
2CJMC:1-84; A:1-84MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE
2CKEB:2-97; C:2-97; D:2-97; A:1-97HUMAN DEATH-ASSOCIATED DRP-1 KINASE IN COMPLEX WITH INHIBITOR
2CLXA:1-844-ARYLAZO-3,5-DIAMINO-1H-PYRAZOLE CDK INHIBITORS: SAR STUDY, CRYSTAL STRUCTURE IN COMPLEX WITH CDK2, SELECTIVITY, AND CELLULAR EFFECTS
2CMWA:44-121STRUCTURE OF HUMAN CASEIN KINASE 1 GAMMA-1 IN COMPLEX WITH 2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE (CASP TARGET)
2CN5A:208-303CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH ADP
2CN8A:212-303CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH DEBROMOHYMENIALDISINE
2DQ7X:1-86CRYSTAL STRUCTURE OF FYN KINASE DOMAIN COMPLEXED WITH STAUROSPORINE
2DS1A:1-84HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR
2DUVA:1-84STRUCTURE OF CDK2 WITH A 3-HYDROXYCHROMONES
2DWBA:126-216AURORA-A KINASE COMPLEXED WITH AMPPNP
2DYLA:119-215CRYSTAL STRUCTURE OF HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 ACTIVATED MUTANT (S287D, T291D)
2E14  [entry was replaced by entry 3W55 without any CATH domain information]
2E2BA:225-317; B:230-317CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH INNO-406
2E9NA:2-97STRUCTURE OF H-CHK1 COMPLEXED WITH A767085
2E9OA:2-97STRUCTURE OF H-CHK1 COMPLEXED WITH AA582939
2E9PA:2-97STRUCTURE OF H-CHK1 COMPLEXED WITH A771129
2E9UA:2-97STRUCTURE OF H-CHK1 COMPLEXED WITH A780125
2E9VA:2-97; B:2-97STRUCTURE OF H-CHK1 COMPLEXED WITH A859017
2EB2A:696-792CRYSTAL STRUCTURE OF MUTATED EGFR KINASE DOMAIN (G719S)
2EB3A:696-792CRYSTAL STRUCTURE OF MUTATED EGFR KINASE DOMAIN (L858R) IN COMPLEX WITH AMPPNP
2ESMB:5-159,B:359-402; A:6-159,A:359-405CRYSTAL STRUCTURE OF ROCK 1 BOUND TO FASUDIL
2ETKB:5-159,B:359-402; A:6-159,A:359-405CRYSTAL STRUCTURE OF ROCK 1 BOUND TO HYDROXYFASUDIL
2ETMB:413-501; A:415-501CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN COMPLEXED WITH 7H-PYRROLO [2,3-D] PYRIMIDINE DERIVATIVE
2ETRB:5-159,B:359-402; A:6-159,A:359-405CRYSTAL STRUCTURE OF ROCK I BOUND TO Y-27632
2EU9A:136-215,A:220-238CRYSTAL STRUCTURE OF CLK3
2EVAA:27-108STRUCTURAL BASIS FOR THE INTERACTION OF TAK1 KINASE WITH ITS ACTIVATING PROTEIN TAB1
2EXCX:48-150INHIBITOR COMPLEX OF JNK3
2EXMA:1-84HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE
2F4JA:227-317STRUCTURE OF THE KINASE DOMAIN OF AN IMATINIB-RESISTANT ABL MUTANT IN COMPLEX WITH THE AURORA KINASE INHIBITOR VX-680
2F57B:-5-525; A:-6-525CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 5
2FB8A:449-533; B:449-533STRUCTURE OF THE B-RAF KINASE DOMAIN BOUND TO SB-590885
2FGIB:465-563; A:465-563CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 1 IN COMPLEX WITH INHIBITOR PD173074
2FO0A:253-336ORGANIZATION OF THE SH3-SH2 UNIT IN ACTIVE AND INACTIVE FORMS OF THE C-ABL TYROSINE KINASE
2FSLX:4-110,X:320-349MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327S) ACTIVATING MUTANT FORM-A
2FSMX:4-110,X:320-349MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327S) ACTIVATING MUTANT FORM-B
2FSOX:5-110,X:320-349MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A) ACTIVATING MUTANT
2FSTX:5-110,X:320-349MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327L) ACTIVATING MUTANT
2FVDA:1-84CYCLIN DEPENDENT KINASE 2 (CDK2) WITH DIAMINOPYRIMIDINE INHIBITOR
2G01A:10-112; B:9-112PYRAZOLOQUINOLONES AS NOVEL, SELECTIVE JNK1 INHIBITORS
2G15A:1046-1159STRUCTURAL CHARACTERIZATION OF AUTOINHIBITED C-MET KINASE
2G1TD:226-317; B:230-317; A:232-317; C:232-317A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
2G2FA:232-317; B:234-317A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
2G2HA:252-336; B:252-336A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
2G2IA:229-317; B:232-317A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN
2G9XC:1-84; A:0-84STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR NU6271
2GDOA:1-974-(AMINOALKYLAMINO)-3-BENZIMIDAZOLE-QUINOLINONES AS POTENT CHK1 INHIBITORS
2GFSA:5-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO3201195
2GHGA:2-97H-CHK1 COMPLEXED WITH A431994
2GMXA:8-112; B:7-112SELECTIVE AMINOPYRIDINE-BASED C-JUN N-TERMINAL KINASE INHIBITORS WITH CELLULAR ACTIVITY
2GQGA:230-317; B:230-317X-RAY CRYSTAL STRUCTURE OF DASATINIB (BMS-354825) BOUND TO ACTIVATED ABL KINASE DOMAIN
2GS2A:672-768CRYSTAL STRUCTURE OF THE ACTIVE EGFR KINASE DOMAIN
2GS6A:669-768CRYSTAL STRUCTURE OF THE ACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AN ATP ANALOG-PEPTIDE CONJUGATE
2GS7B:677-768; A:679-768CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
2GSFA:595-701THE HUMAN EPHA3 RECEPTOR TYROSINE KINASE AND JUXTAMEMBRANE REGION
2GU8A:33-126,A:318-348DISCOVERY OF 2-PYRIMIDYL-5-AMIDOTHIOPHENES AS NOVEL AND POTENT INHIBITORS FOR AKT: SYNTHESIS AND SAR STUDIES
2H6DA:10-95PROTEIN KINASE DOMAIN OF THE HUMAN 5'-AMP-ACTIVATED PROTEIN KINASE CATALYTIC SUBUNIT ALPHA-2 (AMPK ALPHA-2 CHAIN)
2H8HA:259-344SRC KINASE IN COMPLEX WITH A QUINAZOLINE INHIBITOR
2H96A:7-112; B:7-112DISCOVERY OF POTENT, HIGHLY SELECTIVE, AND ORALLY BIOAVAILABLE PYRIDINE CARBOXAMIDE C-JUN NH2-TERMINAL KINASE INHIBITORS
2HAKH:47-135; B:46-131; C:46-131; D:47-131; E:47-131; F:47-131; A:48-131; G:48-131CATALYTIC AND UBIQUTIN-ASSOCIATED DOMAINS OF MARK1/PAR-1
2HCKA:259-344; B:259-344SRC FAMILY KINASE HCK-QUERCETIN COMPLEX
2HIWA:244-335; B:244-335CRYSTAL STRUCTURE OF INACTIVE CONFORMATION ABL KINASE CATALYTIC DOMAIN COMPLEXED WITH TYPE II INHIBITOR
2HK5A:229-318HCK KINASE IN COMPLEX WITH LCK TARGETTED INHIBITOR PG-1009247
2HOGA:2-97CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 20
2HW6A:39-126; B:40-126CRYSTAL STRUCTURE OF MNK1 CATALYTIC DOMAIN
2HW7A:82-161CRYSTAL STRUCTURE OF MNK2-D228G IN COMPLEX WITH STAUROSPORINE
2HXLA:2-97CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 1
2HXQA:2-97CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 2
2HY0A:2-97CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 22
2HY81:249-346PAK1 COMPLEX WITH ST2001
2HYYB:233-317; C:233-317; D:233-317; A:235-317HUMAN ABL KINASE DOMAIN IN COMPLEX WITH IMATINIB (STI571, GLIVEC)
2HZ0B:232-317; A:233-317ABL KINASE DOMAIN IN COMPLEX WITH NVP-AEG082
2HZ4B:233-317; A:234-317; C:234-317ABL KINASE DOMAIN UNLIGATED AND IN COMPLEX WITH TETRAHYDROSTAUROSPORINE
2HZIA:233-317; B:233-317ABL KINASE DOMAIN IN COMPLEX WITH PD180970
2I0EB:339-422,B:620-669; A:339-426,A:621-659STRUCTURE OF CATALYTIC DOMAIN OF HUMAN PROTEIN KINASE C BETA II COMPLEXED WITH A BISINDOLYLMALEIMIDE INHIBITOR
2I0HA:5-110,A:320-349THE STRUCTURE OF P38ALPHA IN COMPLEX WITH AN ARYLPYRIDAZINONE
2I0VA:562-665C-FMS TYROSINE KINASE IN COMPLEX WITH A QUINOLONE INHIBITOR
2I0YA:562-665CFMS TYROSINE KINASE (FGF KID) IN COMPLEX WITH AN ARYLAMIDE INHIBITOR
2I1MA:562-665CFMS TYROSINE KINASE (TIE2 KID) IN COMPLEX WITH AN ARYLAMIDE INHIBITOR
2I40C:1-84; A:1-84CDK2/CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE INHIBITOR
2I6LA:13-112; B:21-112CRYSTAL STRUCTURE OF HUMAN MITOGEN ACTIVATED PROTEIN KINASE 6 (MAPK6)
2IJMA:414-501; B:414-501CRYSTAL STRUCTURE OF FOCAL ADHESION KINASE DOMAIN WITH 2 MOLECULES IN THE ASYMMETRIC UNIT COMPLEXED WITH ADP AND ATP
2IN6A:291-355,A:361-379WEE1 KINASE COMPLEX WITH INHIBITOR PD311839
2IO6A:291-355,A:361-379WEE1 KINASE COMPLEXED WITH INHIBITOR PD330961
2IPXA:89-138HUMAN FIBRILLARIN
2ITPA:697-792CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AEE788
2ITTA:697-792CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AEE788
2ITVA:696-792CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AMP-PNP
2ITWA:696-792CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AFN941
2ITXA:697-792CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
2ITZA:697-792CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH IRESSA
2IVSA:713-806; B:707-806CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED RET TYROSINE KINASE DOMAIN
2IVTA:707-806CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN
2IVUA:707-806CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN COMPLEXED WITH THE INHIBITOR ZD6474
2IVVA:707-806CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN COMPLEXED WITH THE INHIBITOR PP1
2IW6C:1-84; A:1-84STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
2IW8A:1-84; C:1-84STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR
2IW9C:1-84; A:1-84STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
2IWIB:22-120; A:32-120CRYSTAL STRUCTURE OF THE HUMAN PIM2 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1
2IZRA:36-119STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
2IZSA:36-119STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
2IZTA:37-119STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
2IZUA:36-119STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR
2J0IA:300-397CRYSTAL STRUCTURE OF THE HUMAN P21-ACTIVATED KINASE 4
2J2IB:33-124CRYSTAL STRUCTURE OF THE HUMAB PIM1 IN COMPLEX WITH LY333531
2J4ZA:126-216; B:126-216STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-680626
2J50A:128-216; B:128-216STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-739358
2J51A:21-110CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE BOUND TO 5-AMINO-3-((4-(AMINOSULFONYL)PHENYL)AMINO)-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE
2J5EA:696-792CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 13-JAB
2J5FA:696-792CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 34-JAB
2J6MA:697-792CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AEE788
2J7TA:25-112CRYSTAL STRUCTURE OF HUMAN SERINE THREONINE KINASE-10 BOUND TO SU11274
2J9MA:1-84CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH MACROCYCLIC AMINOPYRIMIDINE
2JAMA:19-100; B:19-100CRYSTAL STRUCTURE OF HUMAN CALMODULIN-DEPENDENT PROTEIN KINASE I G
2JAVA:3-45,A:69-89HUMAN KINASE WITH PYRROLE-INDOLINONE LIGAND
2JBOA:59-140PROTEIN KINASE MK2 IN COMPLEX WITH AN INHIBITOR (CRYSTAL FORM-1, SOAKING)
2JBPJ:54-140; A:59-140; B:59-140; C:59-140; D:59-140; E:59-140; F:59-140; G:59-140; H:59-140; K:59-140; L:59-140; I:59-140PROTEIN KINASE MK2 IN COMPLEX WITH AN INHIBITOR (CRYSTAL FORM-2, CO-CRYSTALLIZATION)
2JC6A:11-100; C:11-100CRYSTAL STRUCTURE OF HUMAN CALMODULIN-DEPENDENT PROTEIN KINASE 1D
2JDOA:146-235,A:430-473STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL) AMIDE
2JDRA:146-235,A:430-473STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH THE INHIBITOR A-443654
2JEDB:375-463,B:674-711; A:375-464,A:655-694THE CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF THE PROTEIN KINASE C THETA IN COMPLEX WITH NVP-XAA228 AT 2.32A RESOLUTION.
2JFLA:21-110CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE ( DIPHOSPHORYLATED FORM) BOUND TO 5- AMINO-3-((4-( AMINOSULFONYL)PHENYL)AMINO)-N-(2,6- DIFLUOROPHENYL)-1H-1,2, 4-TRIAZOLE-1-CARBOTHIOAMIDE
2JFMA:21-110CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE (UNLIGANDED FORM)
2JGZA:0-84CRYSTAL STRUCTURE OF PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B
2JIIA:141-261; B:137-261STRUCTURE OF VACCINIA RELATED KINASE 3
2JITB:697-792; A:696-792CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION
2JIUA:696-792; B:695-792CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPLEX WITH AEE788
2JIVB:699-792; A:700-792CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPEX WITH HKI-272
2JLDB:40-136; A:53-136EXTREMELY TIGHT BINDING OF RUTHENIUM COMPLEX TO GLYCOGEN SYNTHASE KINASE 3
2NO3A:8-112; B:7-112NOVEL 4-ANILINOPYRIMIDINES AS POTENT JNK1 INHIBITORS
2NP8A:128-216STRUCTURAL BASIS FOR THE INHIBITION OF AURORA A KINASE BY A NOVEL CLASS OF HIGH AFFINITY DISUBSTITUTED PYRIMIDINE INHIBITORS
2NPQA:4-110,A:320-349A NOVEL LIPID BINDING SITE IN THE P38 ALPHA MAP KINASE
2NRUA:164-264; C:164-264; D:164-264; B:163-264CRYSTAL STRUCTURE OF IRAK-4
2NRYD:164-264; C:164-264; A:164-264; B:164-264CRYSTAL STRUCTURE OF IRAK-4
2O0UA:48-150CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH N-{3-CYANO-6-[3-(1-PIPERIDINYL)PROPANOYL]-4,5,6,7-TETRAHYDROTHIENO[2,3-C]PYRIDIN-2-YL}-1-NAPHTHALENECARBOXAMIDE
2O2UA:48-150CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH N-(3-CYANO-4,5,6,7-TETRAHYDRO-1-BENZOTHIEN-2-YL)-2-FLUOROBENZAMIDE
2O3PA:33-124CRYSTAL STRUCTURE OF PIM1 WITH QUERCETIN
2O5KA:53-136CRYSTAL STRUCTURE OF GSK3BETA IN COMPLEX WITH A BENZOIMIDAZOL INHIBITOR
2O63A:33-124CRYSTAL STRUCTURE OF PIM1 WITH MYRICETIN
2O64A:33-124CRYSTAL STRUCTURE OF PIM1 WITH QUERCETAGETIN
2O65A:33-124CRYSTAL STRUCTURE OF PIM1 WITH PENTAHYDROXYFLAVONE
2O8YA:165-264; B:165-264APO IRAK4 KINASE DOMAIN
2OBJA:33-124CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH INHIBITOR
2OF2A:231-318CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 8 BOUND TO LCK
2OF4A:231-318CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 1 BOUND TO LCK
2OFUA:229-318X-RAY CRYSTAL STRUCTURE OF 2-AMINOPYRIMIDINE CARBAMATE 43 BOUND TO LCK
2OFVB:232-320; A:231-320CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 1 BOUND TO LCK
2OG8B:236-320; A:237-320CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 36 BOUND TO LCK
2OGVA:562-665CRYSTAL STRUCTURE OF THE AUTOINHIBITED HUMAN C-FMS KINASE DOMAIN
2OH4A:814-916CRYSTAL STRUCTURE OF VEGFR2 WITH A BENZIMIDAZOLE-UREA INHIBITOR
2OI4X:32-124CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH FLUORINATED RUTHENIUM PYRIDOCARBAZOLE
2OIBA:162-264; D:162-264; C:161-264; B:164-264CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN APO FORM
2OICD:161-264; C:161-264; A:163-264; B:164-264CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN COMPLEXED WITH STAUROSPORINE
2OIDB:164-264; D:164-264; A:164-264; C:166-264CRYSTAL STRUCTURE OF IRAK4 KINASE DOMAIN COMPLEXED WITH AMPPNP
2OJ9A:954-1048STRUCTURE OF IGF-1R KINASE DOMAIN COMPLEXED WITH A BENZIMIDAZOLE INHIBITOR
2OJGA:17-105,A:337-354CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
2OJIA:13-105,A:337-354CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-BENZYL-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
2OJJA:13-105,A:337-354CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH (S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
2OK1A:48-150CRYSTAL STRUCTURE OF JNK3 BOUND TO N-BENZYL-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
2OKRA:5-110,A:320-349; D:5-110,D:320-349CRYSTAL STRUCTURE OF THE P38A-MAPKAP KINASE 2 HETERODIMER
2ONLC:46-142; D:46-142; A:5-110,A:320-349; B:5-110,B:320-349CRYSTAL STRUCTURE OF THE P38A-MAPKAP KINASE 2 HETERODIMER
2OO8X:836-907SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS
2OSCA:837-907SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS
2OU7A:48-136STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN POLO-LIKE KINASE 1
2OW3A:40-136; B:40-136GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH BIS-(INDOLE)MALEIMIDE PYRIDINOPHANE INHIBITOR
2OWBA:48-136STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN POLO-LIKE KINASE 1
2OZAA:51-142; B:6-110,B:320-349STRUCTURE OF P38ALPHA COMPLEX
2OZOA:329-418AUTOINHIBITED INTACT HUMAN ZAP-70
2P0CA:575-673; B:575-673CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER
2P2HA:815-918CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDINYL-TRIAZINE INHIBITOR
2P2IA:817-918; B:820-918CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NICOTINAMIDE INHIBITOR
2P33A:48-150SYNTHESIS AND SAR OF AMINOPYRIMIDINES AS NOVEL C-JUN N-TERMINAL KINASE (JNK) INHIBITORS
2P3GX:59-140CRYSTAL STRUCTURE OF A PYRROLOPYRIDINE INHIBITOR BOUND TO MAPKAP KINASE-2
2P4IB:836-907; A:838-907EVOLUTION OF A HIGHLY SELECTIVE AND POTENT 2-(PYRIDIN-2-YL)-1,3,5-TRIAZINE TIE-2 KINASE INHIBITOR
2P55A:61-146X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
2PE0A:74-165CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 5-HYDROXY-3-[1-(1H-PYRROL-2-YL)-ETH-(Z)-YLIDENE]-1,3-DIHYDRO-INDOL-2-ONE COMPLEX
2PE1A:74-165CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) {2-OXO-3-[1-(1H-PYRROL-2-YL)-ETH-(Z)-YLIDENE]-2,3-DIHYDRO-1H-INDOL-5-YL}-UREA {BX-517} COMPLEX
2PE2A:74-165CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 3-{5-[2-OXO-5-UREIDO-1,2-DIHYDRO-INDOL-(3Z)-YLIDENEMETHYL]-1H-PYRROL-3-YL}-N-(2-PIPERIDIN-1-YL-ETHYL)-BENZAMIDE COMPLEX
2PKJ  [entry was replaced by entry 3MH0 without any CATH domain information]
2PL0A:231-318LCK BOUND TO IMATINIB
2PSQB:467-566; A:468-566CRYSTAL STRUCTURE OF UNPHOSPHORYLATED UNACTIVATED WILD TYPE FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN
2PTJ  [entry was replaced by entry 3MH3 without any CATH domain information]
2PTO  [entry was replaced by entry 3MH2 without any CATH domain information]
2PV5  [entry was replaced by entry 3MGY without any CATH domain information]
2PV8  [entry was replaced by entry 3MH1 without any CATH domain information]
2PVFA:467-566CRYSTAL STRUCTURE OF TYROSINE PHOSPHORYLATED ACTIVATED FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN IN COMPLEX WITH ATP ANALOG AND SUBSTRATE PEPTIDE
2PVRA:25-115CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 (C-TERMINAL DELETION MUTANT 1-335) IN COMPLEX WITH TWO SULFATE IONS
2PVYA:467-566; D:467-566; B:462-566; C:462-566CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K659N MUTATION RESPONSIBLE FOR AN UNCLASSIFIED CRANIOSYNOSTOSIS SYNDROME.
2PWLB:468-566; A:467-566CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549H MUTATION RESPONSIBLE FOR CROUZON SYNDROME.
2PY3A:468-566; B:468-566CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565G MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
2PZ5A:468-566; B:468-566CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC N549T MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
2PZPA:468-566; B:468-566CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K526E MUTATION RESPONSIBLE FOR CROUZON SYNDROME
2PZRB:467-566; A:468-566CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC K641R MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
2PZYA:59-140; B:59-140; C:59-140; D:59-140STRUCTURE OF MK2 COMPLEXED WITH COMPOUND 76
2Q0BA:468-566; B:468-566CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAIN HARBORING THE PATHOGENIC E565A MUTATION RESPONSIBLE FOR PFEIFFER SYNDROME
2Q0NA:298-397STRUCTURE OF HUMAN P21 ACTIVATING KINASE 4 (PAK4) IN COMPLEX WITH A CONSENSUS PEPTIDE
2QD9A:5-110,A:320-349P38 ALPHA MAP KINASE INHIBITOR BASED ON HETEROBICYCLIC SCAFFOLDS
2QHMA:2-97CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 2A
2QHNA:2-97CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 1A
2QLUA:188-269CRYSTAL STRUCTURE OF ACTIVIN RECEPTOR TYPE II KINASE DOMAIN FROM HUMAN
2QNJB:43-134; A:43-134KINASE AND UBIQUITIN-ASSOCIATED DOMAINS OF MARK3/PAR-1
2QO2A:595-701HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATED, APO STRUCTURE
2QO7A:595-700HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATED, AMP-PNP BOUND
2QO9A:608-702HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, PHOSPHORYLATED, AMP-PNP BOUND
2QOBA:609-702HUMAN EPHA3 KINASE DOMAIN, BASE STRUCTURE
2QOCA:613-702HUMAN EPHA3 KINASE DOMAIN, PHOSPHORYLATED, AMP-PNP BOUND STRUCTURE
2QODA:595-701HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y602F MUTANT
2QOFA:595-701HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F MUTANT
2QOIA:595-701HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F DOUBLE MUTANT
2QOKA:595-701HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:S768A TRIPLE MUTANT
2QOLA:595-701HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596:Y602:S768G TRIPLE MUTANT
2QONA:595-700HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y742A TRIPLE MUTANT
2QOOA:595-701HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y742F TRIPLE MUTANT
2QOQA:595-700HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, BASE, AMP-PNP BOUND STRUCTURE
2QU5A:816-918CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZIMIDAZOLE INHIBITOR
2QU6B:822-918; A:817-918CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZOXAZOLE INHIBITOR
2R0UA:2-97CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 54
2R2PA:662-755KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 5 (EPHA5)
2R3FA:1-84CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3GA:1-84CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3HA:1-84CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3IA:1-84CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3JA:1-84CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3KA:1-84CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3LA:1-84CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3MA:1-84CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3NA:1-84CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3OA:1-84CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3PA:1-84CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3QA:1-84CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R3RA:1-84CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR
2R4BB:694-798; A:694-798ERBB4 KINASE DOMAIN COMPLEXED WITH A THIENOPYRIMIDINE INHIBITOR
2R5TA:88-182CRYSTAL STRUCTURE OF INACTIVE SERUM AND GLUCOCORTICOID-REGULATED KINASE 1 IN COMPLEX WITH AMP-PNP
2R7BA:75-165CRYSTAL STRUCTURE OF THE PHOSPHOINOSITIDE-DEPENDENT KINASE-1 (PDK-1)CATALYTIC DOMAIN BOUND TO A DIBENZONAPHTHYRIDINE INHIBITOR
2R9SA:48-150; B:48-150C-JUN N-TERMINAL KINASE 3 WITH 3,5-DISUBSTITUTED QUINOLINE INHIBITOR
2REIA:607-713KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7)
2RF9A:675-768; B:677-768CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
2RFDA:679-768; B:679-768CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
2RFEA:677-768; B:679-768; D:679-768; C:678-768CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE
2RFNA:1061-1159; B:1061-1159X-RAY STRUCTURE OF C-MET WITH INHIBITOR.
2RFSA:1067-1159X-RAY STRUCTURE OF SU11274 BOUND TO C-MET
2RG5A:4-110,A:320-349PHENYLALANINE PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 11B
2RG6A:4-110,A:320-349PHENYLALANINE PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 11J
2RGPA:702-792STRUCTURE OF EGFR IN COMPLEX WITH HYDRAZONE, A POTENT DUAL INHIBITOR
2RKUA:48-136STRUCTURE OF PLK1 IN COMPLEX WITH BI2536
2RL5A:815-918CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A 2,3-DIHYDRO-1,4-BENZOXAZINE INHIBITOR
2SRCA:259-344CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC, IN COMPLEX WITH AMP-PNP
2UUEA:1-84; C:1-84REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS
2UV2A:21-110CRYSTAL STRUCTURE OF HUMAN STE20-LIKE KINASE BOUND TO 4-(4-( 5-CYCLOPROPYL-1H-PYRAZOL-3-YLAMINO)-QUINAZOLIN-2-YLAMINO)-PHENYL)-ACETONITRILE
2UW9A:146-235,A:430-473STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH 4-(4-CHLORO-PHENYL)-4-(4-(1H-PYRAZOL-4-YL)-PHENYL)-PIPERIDINE
2UZBA:1-84; C:1-84CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZDA:1-84; C:1-84CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZEA:1-84; C:1-84CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZLA:1-84; C:1-84CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZNA:1-84CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2UZOA:1-84CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2V0DA:1-84CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR
2V22A:1-84; C:1-84REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS
2V55A:6-159,A:359-404; C:6-159,C:359-404MECHANISM OF MULTI-SITE PHOSPHORYLATION FROM A ROCK-I:RHOE COMPLEX STRUCTURE
2V5QA:48-136; B:48-136CRYSTAL STRUCTURE OF WILD-TYPE PLK-1 KINASE DOMAIN IN COMPLEX WITH A SELECTIVE DARPIN
2V7AA:233-317; B:234-317CRYSTAL STRUCTURE OF THE T315I ABL MUTANT IN COMPLEX WITH THE INHIBITOR PHA-739358
2VAGA:0-220,A:225-243CRYSTAL STRUCTURE OF DI-PHOSPHORYLATED HUMAN CLK1 IN COMPLEX WITH A NOVEL SUBSTITUTED INDOLE INHIBITOR
2VD5B:11-154,B:363-416; A:11-154,A:363-416STRUCTURE OF HUMAN MYOTONIC DYSTROPHY PROTEIN KINASE IN COMPLEX WITH THE BISINDOYLMALEIDE INHIBITOR BIM VIII
2VTAA:1-84IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTHA:1-84IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN
2VTIA:1-84IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTJA:1-84IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTLA:1-84IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTMA:1-84IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTNA:1-84IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTOA:1-84IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTPA:1-84IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTQA:1-84IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTRA:1-84IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTSA:1-84IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VTTA:1-84IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VU3A:1-84IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
2VV9A:1-84CDK2 IN COMPLEX WITH AN IMIDAZOLE PIPERAZINE
2VWUA:609-695EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWVA:606-695EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWWA:609-695EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWXA:608-695EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWYA:608-695EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VWZA:608-695EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VX0A:608-695EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2VX1A:608-695EPHB4 KINASE DOMAIN INHIBITOR COMPLEX
2W05A:1-84STRUCTURE OF CDK2 IN COMPLEX WITH AN IMIDAZOLYL PYRIMIDINE, COMPOUND 5B
2W06A:1-84STRUCTURE OF CDK2 IN COMPLEX WITH AN IMIDAZOLYL PYRIMIDINE, COMPOUND 5C
2W0JA:210-303CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH NSC 109555, A SPECIFIC INHIBITOR
2W17A:1-84CDK2 IN COMPLEX WITH THE IMIDAZOLE PYRIMIDINE AMIDE, COMPOUND (S)-8B
2W1CA:128-216STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W1DA:128-216STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W1EA:128-216STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W1FA:128-216STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W1GA:128-216STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR
2W1HA:1-84FRAGMENT-BASED DISCOVERY OF THE PYRAZOL-4-YL UREA (AT9283), A MULTI-TARGETED KINASE INHIBITOR WITH POTENT AURORA KINASE ACTIVITY
2W4JA:8-98X-RAY STRUCTURE OF A DAP-KINASE 2-277
2W4KA:2-97X-RAY STRUCTURE OF A DAP-KINASE 2-302
2W4OA:34-120CRYSTAL STRUCTURE OF HUMAN CAMK4 IN COMPLEX WITH 4-AMINO( SULFAMOYL-PHENYLAMINO)-TRIAZOLE-CARBOTHIOIC ACID (2,6-DIFLUORO-PHENYL)-AMIDE)
2W5AA:3-45,A:69-89HUMAN NEK2 KINASE ADP-BOUND
2W5BA:3-45,A:69-89HUMAN NEK2 KINASE ATPGAMMAS-BOUND
2W5HA:3-47,A:69-89HUMAN NEK2 KINASE APO
2W7XA:210-303CELLULAR INHIBITION OF CHECKPOINT KINASE 2 AND POTENTIATION OF CYTOTOXIC DRUGS BY NOVEL CHK2 INHIBITOR PV1019
2W96B:4-97CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN
2W99B:4-97CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN
2W9FB:5-97CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN
2W9ZB:4-97CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN
2WAJA:48-150CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH A 1-ARYL-3,4-DIHYDROISOQUINOLINE INHIBITOR
2WD1A:1055-1159HUMAN C-MET KINASE IN COMPLEX WITH AZAINDOLE INHIBITOR
2WEVA:1-84; C:1-84TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
2WFYA:1-84; C:1-84TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
2WGJA:1052-1159X-RAY STRUCTURE OF PF-02341066 BOUND TO THE KINASE DOMAIN OF C-MET
2WHBA:1-84; C:1-84TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
2WIHA:1-84; C:1-84STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125
2WIPA:1-84; C:1-84STRUCTURE OF CDK2-CYCLIN A COMPLEXED WITH 8-ANILINO-1-METHYL-4,5-DIHYDRO-1H-PYRAZOLO[4,3-H] QUINAZOLINE-3-CARBOXYLIC ACID
2WKMA:1059-1159X-RAY STRUCTURE OF PHA-00665752 BOUND TO THE KINASE DOMAIN OF C-MET
2WMQA:7-97CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMRA:7-97CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMSA:7-97CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMTA:8-97CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMUA:9-97CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMVA:7-97CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMWA:7-97CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WMXA:7-97CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2WOTA:198-284ALK5 IN COMPLEX WITH 4-((5,6-DIMETHYL-2-(2-PYRIDYL)-3-PYRIDYL)OXY)-N-(3,4,5-TRIMETHOXYPHENYL)PYRIDIN-2-AMINE
2WOUA:198-284ALK5 IN COMPLEX WITH 4-((4-((2,6-DIMETHYL-3-PYRIDYL)OXY)-2-PYRIDYL)AMINO)BENZENESULFONAMIDE
2WPAA:1-84; C:1-84OPTIMISATION OF 6,6-DIMETHYL PYRROLO 3,4-C PYRAZOLES: IDENTIFICATION OF PHA-793887, A POTENT CDK INHIBITOR SUITABLE FOR INTRAVENOUS DOSING
2WQBA:816-904STRUCTURE OF THE TIE2 KINASE DOMAIN IN COMPLEX WITH A THIAZOLOPYRIMIDINE INHIBITOR
2WQOA:3-45,A:69-89STRUCTURE OF NEK2 BOUND TO THE AMINOPYRIDINE CCT241950
2WTCA:211-303CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR
2WTDA:210-303CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR
2WTIA:210-303CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR
2WTJA:209-303CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR
2WTKC:47-131,C:336-342; F:45-131,F:336-340STRUCTURE OF THE HETEROTRIMERIC LKB1-STRADALPHA-MO25ALPHA COMPLEX
2WTVA:128-216; B:128-216; C:128-216; D:128-216AURORA-A INHIBITOR STRUCTURE
2WTWA:128-216AURORA-A INHIBITOR STRUCTURE (2ND CRYSTAL FORM)
2WU6A:134-215,A:220-238CRYSTAL STRUCTURE OF THE HUMAN CLK3 IN COMPLEX WITH DKI
2WU7A:135-215,A:220-238CRYSTAL STRUCTURE OF THE HUMAN CLK3 IN COMPLEX WITH V25
2WXVA:1-84; C:1-84STRUCTURE OF CDK2-CYCLIN A WITH A PYRAZOLO(4,3-H) QUINAZOLINE-3-CARBOXAMIDE INHIBITOR
2X0GA:9-95X-RAY STRUCTURE OF A DAP-KINASE CALMODULIN COMPLEX
2X1NA:1-84; C:1-84TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2, CYCLIN A THROUGH STRUCTURE GUIDED DESIGN
2X2KA:707-806CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
2X2LA:707-806CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
2X2MB:707-806; A:707-806CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMAIN WITH INHIBITOR
2X39A:146-235,A:430-473STRUCTURE OF 4-AMINO-N-(4-CHLOROBENZYL)-1-(7H-PYRROLO(2,3-D) PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE BOUND TO PKB
2X6DA:126-216AURORA-A BOUND TO AN INHIBITOR
2X6EA:126-216AURORA-A BOUND TO AN INHIBITOR
2X7GA:81-145,A:157-179STRUCTURE OF HUMAN SERINE-ARGININE-RICH PROTEIN-SPECIFIC KINASE 2 (SRPK2) BOUND TO PURVALANOL B
2X81A:128-216STRUCTURE OF AURORA A IN COMPLEX WITH MLN8054
2X8DA:2-97DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION
2X8EA:9-97DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION
2X8IA:2-97DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION
2XB7A:1095-1198STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH NVP-TAE684
2XBAA:1095-1198STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH PHA-E429
2XCHA:73-165CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR
2XCKA:76-165CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR
2XEYA:6-97CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2XEZA:7-97CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2XF0A:4-97CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS
2XH5A:146-235,A:430-473STRUCTURE OF 4-(4-TERT-BUTYLBENZYL)-1-(7H-PYRROLO(2,3-D) PYRIMIDIN-4-YL)PIPERIDIN-4-AMINE BOUND TO PKB
2XNEA:128-216STRUCTURE OF AURORA-A BOUND TO AN IMIDAZOPYRAZINE INHIBITOR
2XNGA:127-216STRUCTURE OF AURORA-A BOUND TO A SELECTIVE IMIDAZOPYRAZINE INHIBITOR
2XP2A:1093-1198STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CRIZOTINIB (PF-02341066)
2YWPA:2-97CRYSTAL STRUCTURE OF CHK1 WITH A UREA INHIBITOR
2YZAA:10-95CRYSTAL STRUCTURE OF KINASE DOMAIN OF HUMAN 5'-AMP-ACTIVATED PROTEIN KINASE ALPHA-2 SUBUNIT MUTANT (T172D)
2Z2WA:291-355,A:361-379HUMAN WEE1 KINASE COMPLEXED WITH INHIBITOR PF0335770
2Z7QA:56-147CRYSTAL STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF HUMAN RSK-1 BOUND TO AMP-PCP
2Z7RA:53-147CRYSTAL STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF HUMAN RSK1 BOUND TO STAUROSPORINE
2Z7SA:56-147CRYSTAL STRUCTURE OF THE N-TERMINAL KINASE DOMAIN OF HUMAN RSK1 BOUND TO PURVALNOL A
2Z8CA:984-1078PHOSPHORYLATED INSULIN RECEPTOR TYROSINE KINASE IN COMPLEX WITH (4-{[5-CARBAMOYL-4-(3-METHYLANILINO)PYRIMIDIN-2-YL]AMINO}PHENYL)ACETIC ACID
2ZAZA:18-110CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH 4-ANILINO QUINOLINE INHIBITOR
2ZB0A:18-110CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH BIPHENYL AMIDE INHIBITOR
2ZB1A:18-110CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH BIPHENYL AMIDE INHIBITOR
2ZDTA:48-150CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH AN ISOQUINOLONE INHIBITOR
2ZDUA:48-150CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH AN ISOQUINOLONE INHIBITOR
2ZJWA:25-115CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA COMPLEXED WITH ELLAGIC ACID
2ZM1A:231-318CRYSTAL STRUCTURE OF IMIDAZO PYRAZIN 1 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
2ZM3A:980-1078; B:980-1078; C:980-1078; D:980-1078COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND ISOQUINOLINEDIONE INHIBITOR
2ZM4A:231-318CRYSTAL STRUCTURE OF IMIDAZO QUINOXALINE 1 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394)
2ZOQA:24-124,A:356-373; B:24-124,B:356-373STRUCTURAL DISSECTION OF HUMAN MITOGEN-ACTIVATED KINASE ERK1
2ZV2A:161-270CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE KINASE 2, BETA, CAMKK2 KINASE DOMAIN IN COMPLEX WITH STO-609
2ZYBA:231-318CRYSTAL STRUCTURE OF PHENYLIMIDAZO PYRAZIN 2 BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3A2CA:59-140; B:59-140; D:59-140; E:59-140; F:59-140; G:59-140; I:59-140; J:59-140; K:59-140; L:59-140; C:59-140; H:59-140CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR COMPLEX BOUND TO MAPKAP KINASE-2 (MK2)
3A4OX:7-90LYN KINASE DOMAIN
3A4PA:1063-1159HUMAN C-MET KINASE DOMAIN COMPLEXED WITH 6-BENZYLOXYQUINOLINE INHIBITOR
3A60A:85-178; B:85-178CRYSTAL STRUCTURE OF UNPHOSPHORYLATED P70S6K1 (FORM I)
3A61A:87-178CRYSTAL STRUCTURE OF UNPHOSPHORYLATED P70S6K1 (FORM II)
3A62A:85-178CRYSTAL STRUCTURE OF PHOSPHORYLATED P70S6K1
3A8WA:237-329,A:534-574; B:237-329,B:534-574CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN
3A8XB:236-329,B:534-574; A:237-329,A:534-574CRYSTAL STRUCTURE OF PKCIOTA KINASE DOMAIN
3AC1A:231-318CRYSTAL STRUCTURE OF PYRAZIN DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AC2A:231-318CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AC3A:231-318CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AC4A:231-318CRYSTAL STRUCTURE OF TRIAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AC5A:231-318CRYSTAL STRUCTURE OF TRIAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3AC8A:231-318CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3ACJA:231-318CRYSTAL STRUCTURE OF IMIDAZO PYRIMIDINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3ACKA:231-318CRYSTAL STRUCTURE OF PYRROLO PYRAZINE DERIVATIVE BOUND TO THE KINASE DOMAIN OF HUMAN LCK, (AUTO-PHOSPHORYLATED ON TYR394)
3B2TB:468-566; A:468-566STRUCTURE OF PHOSPHOTRANSFERASE
3B2WA:238-320CRYSTAL STRUCTURE OF PYRIMIDINE AMIDE 11 BOUND TO LCK
3B8QB:820-918; A:818-918CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NAPHTHAMIDE INHIBITOR
3B8RB:821-918; A:818-918CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A NAPHTHAMIDE INHIBITOR
3BBTB:683-773; D:684-773CRYSTAL STRUCTURE OF THE ERBB4 KINASE IN COMPLEX WITH LAPATINIB
3BBWA:683-773; B:683-773CRYSTAL STRUCTURE OF THE ERBB4 KINASE IN ITS INACTIVE CONFORMATION
3BCEA:678-773; B:678-773; C:678-773CRYSTAL STRUCTURE OF THE ERBB4 KINASE
3BE2A:815-918CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZAMIDE INHIBITOR
3BEAA:562-665CFMS TYROSINE KINASE (TIE2 KID) IN COMPLEX WITH A PYRIMIDINOPYRIDONE INHIBITOR
3BEGA:69-133,A:145-167CRYSTAL STRUCTURE OF SR PROTEIN KINASE 1 COMPLEXED TO ITS SUBSTRATE ASF/SF2
3BELA:702-792X-RAY STRUCTURE OF EGFR IN COMPLEX WITH OXIME INHIBITOR
3BGPA:33-124HUMAN PIM-1 COMPLEXED WITH A BENZOISOXAZOLE INHIBITOR VX1
3BGQA:33-124HUMAN PIM-1 KINASE IN COMPLEX WITH AN TRIAZOLO PYRIDAZINE INHIBITOR VX2
3BGZA:33-124HUMAN PIM-1 KINASE IN COMPLEX WITH DIPHENYL INDOLE INHIBITOR VX3
3BHTC:1-84; A:-1-84STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 3
3BHUC:1-84; A:-1-84STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR MERIOLIN 5
3BHVC:1-84; A:-1-84STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR VARIOLIN B
3BI6A:293-355,A:361-379WEE1 KINASE COMPLEX WITH INHIBITOR PD352396
3BIZA:293-355,A:362-379WEE1 KINASE COMPLEX WITH INHIBITOR PD331618
3BKBA:553-642CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V-FES)
3BLHA:8-107CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1
3BLQA:7-107CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1 IN COMPLEX WITH ATP
3BLRA:7-107CRYSTAL STRUCTURE OF HUMAN CDK9/CYCLINT1 IN COMPLEX WITH FLAVOPIRIDOL
3BPRA:575-673; C:575-673; D:575-673; B:576-673CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR C52
3BQCA:25-115HIGH PH-VALUE CRYSTAL STRUCTURE OF EMODIN IN COMPLEX WITH THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
3BRBB:575-673; A:575-673CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH ADP
3BU3A:987-1078CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PEPTIDE
3BU5A:987-1078CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PEPTIDE AND ATP
3BU6A:987-1078CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH IRS2 KRLB PHOSPHOPEPTIDE
3BV2A:5-110,A:320-349MORPHOLINO PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 30
3BV3A:5-110,A:320-349MORPHOLINO PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 2
3BWFA:33-124CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH AN OSMIUM COMPOUND
3BX5A:5-110,A:320-349P38 ALPHA MAP KINASE COMPLEXED WITH BMS-640994
3BYMA:230-318X-RAY CO-CRYSTAL STRUCTURE AMINOBENZIMIDAZOLE TRIAZINE 1 BOUND TO LCK
3BYOA:231-318X-RAY CO-CRYSTAL STRUCTURE OF 2-AMINO-6-PHENYLPYRIMIDO[5', 4':5,6]PYRIMIDO[1,2-A]BENZIMIDAZOL-5(6H)-ONE 25 BOUND TO LCK
3BYSA:230-320CO-CRYSTAL STRUCTURE OF LCK AND AMINOPYRIMIDINE AMIDE 10B
3BYUA:231-320CO-CRYSTAL STRUCTURE OF LCK AND AMINOPYRIMIDINE REVERSE AMIDE 23
3BZ3A:414-501CRYSTAL STRUCTURE ANALYSIS OF FOCAL ADHESION KINASE WITH A METHANESULFONAMIDE DIAMINOPYRIMIDINE INHIBITOR
3C0HA:5-93; B:5-93CASK CAM-KINASE DOMAIN- AMPPNP COMPLEX, P1 FORM
3C0IA:6-93CASK CAM-KINASE DOMAIN- 3'-AMP COMPLEX, P212121 FORM
3C13A:25-115LOW PH-VALUE CRYSTAL STRUCTURE OF EMODIN IN COMPLEX WITH THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2
3C1XA:1061-1159CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A PYRROLOTRIAZINE BASED INHIBITOR
3C4CA:448-533; B:448-533B-RAF KINASE IN COMPLEX WITH PLX4720
3C4D  [entry was replaced by entry 4FK3 without any CATH domain information]
3C4EA:33-124; B:33-124; D:33-124; C:34-124PIM-1 KINASE DOMAIN IN COMPLEX WITH 3-AMINOPHENYL-7-AZAINDOLE
3C4FA:465-563; B:465-563FGFR TYROSINE KINASE DOMAIN IN COMPLEX WITH 3-(3-METHOXYBENZYL)-7-AZAINDOLE
3C5UA:4-110,A:320-349P38 ALPHA MAP KINASE COMPLEXED WITH A BENZOTHIAZOLE BASED INHIBITOR
3C7QA:819-918STRUCTURE OF VEGFR2 KINASE DOMAIN IN COMPLEX WITH BIBF1120
3CBLA:553-642CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V-FES) IN COMPLEX WITH STAUROSPORINE AND A CONSENSUS PEPTIDE
3CC6A:415-504CRYSTAL STRUCTURE OF KINASE DOMAIN OF PROTEIN TYROSINE KINASE 2 BETA (PTK2B)
3CCNA:1055-1159X-RAY STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR.
3CD3A:553-642CRYSTAL STRUCTURE OF PHOSPHORYLATED HUMAN FELINE SARCOMA VIRAL ONCOGENE HOMOLOGUE (V-FES) IN COMPLEX WITH STAUROSPORINE AND A CONSENSUS PEPTIDE
3CD8A:1054-1159X-RAY STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR.
3CE3A:1061-1159CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A PYRROLOPYRIDINEPYRIDONE BASED INHIBITOR
3CGFA:48-150IRAK-4 INHIBITORS (PART II)- A STRUCTURE BASED ASSESSMENT OF IMIDAZO[1,2 A]PYRIDINE BINDING
3CGOA:48-150IRAK-4 INHIBITORS (PART II)- A STRUCTURE BASED ASSESSMENT OF IMIDAZO[1,2 A]PYRIDINE BINDING
3CIKA:186-275,A:495-512HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS
3CJFA:815-916CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 3,4,5-TRIMETHOXY ANILINE CONTAINING PYRIMIDINE
3CJGA:814-916CRYSTAL STRUCTURE OF VEGFR2 IN COMPLEX WITH A 3,4,5-TRIMETHOXY ANILINE CONTAINING PYRIMIDINE
3CKWA:5-86CRYSTAL STRUCTURE OF STERILE 20-LIKE KINASE 3 (MST3, STK24)
3CKXA:5-86CRYSTAL STRUCTURE OF STERILE 20-LIKE KINASE 3 (MST3, STK24) IN COMPLEX WITH STAUROSPORINE
3CLYA:1468-1566CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAINS TRAPPED IN TRANS-PHOSPHORYLATION REACTION
3COHA:128-216; B:128-216CRYSTAL STRUCTURE OF AURORA-A IN COMPLEX WITH A PENTACYCLIC INHIBITOR
3COIA:19-111CRYSTAL STRUCTURE OF P38DELTA KINASE
3COKA:6-94; B:6-94CRYSTAL STRUCTURE OF PLK4 KINASE
3COMB:16-104; A:29-104CRYSTAL STRUCTURE OF MST1 KINASE
3CP9B:819-918; A:817-918CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDONE INHIBITOR
3CPBA:819-918; B:820-918CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BISAMIDE INHIBITOR
3CPCA:820-918; B:820-918CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRIDONE INHIBITOR
3CQUA:144-233,A:429-472CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR
3CQWA:144-233,A:429-472CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR
3CS9B:233-317; A:233-317; C:232-317; D:233-317HUMAN ABL KINASE IN COMPLEX WITH NILOTINIB
3CTHA:1061-1159CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A AMINOPYRIDINE BASED INHIBITOR
3CTJA:1061-1159CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A AMINOPYRIDINE BASED INHIBITOR
3D4QA:448-533; B:448-533PYRAZOLE-BASED INHIBITORS OF B-RAF KINASE
3D7TB:258-340; A:188-268STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIVATOR CSK
3D7ZA:18-110CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIPHENYL AMIDE INHIBITOR
3D94A:956-1051CRYSTAL STRUCTURE OF THE INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE IN COMPLEX WITH PQIP
3D9VB:5-159,B:359-402; A:6-159,A:359-405CRYSTAL STRUCTURE OF ROCK I BOUND TO H-1152P A DI-METHYLATED VARIANT OF FASUDIL
3DA6A:48-150CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH N-(3-METHYL-4-(3-(2-(METHYLAMINO)PYRIMIDIN-4-YL)PYRIDIN-2-YLOXY) NAPHTHALEN-1-YL)-1H-BENZO[D]IMIDAZOL-2-AMINE
3DDPA:0-84; C:0-84STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR CR8
3DDQC:1-84; A:0-84STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR ROSCOVITINE
3DFCB:15-105CRYSTAL STRUCTURE OF A GLYCINE-RICH LOOP MUTANT OF THE DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN WITH AMPPNP
3DGKA:15-105CRYSTAL STRUCTURE OF A GLYCINE-RICH LOOP MUTANT OF THE DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN
3DKCA:1061-1159STRUCTURE OF MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH ATP
3DKFA:1061-1159STRUCTURE OF MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH INHIBITOR SGX-523
3DKGA:1061-1159STRUCTURE OF MUTANT(Y1248L) MET RECEPTOR TYROSINE KINASE IN COMPLEX WITH INHIBITOR SGX-523
3DKOA:607-713COMPLEX BETWEEN THE KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7) AND INHIBITOR ALW-II-49-7
3DOGC:1-84; A:0-84STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR N-&-N1
3DPKA:562-665CFMS TYROSINE KINASE IN COMPLEX WITH A PYRIDOPYRIMIDINONE INHIBITOR
3DS6A:5-110,A:320-349; B:5-110,B:320-349; C:5-110,C:320-349; D:5-110,D:320-349P38 COMPLEX WITH A PHTHALAZINE INHIBITOR
3DT1A:-3-110,A:320-349P38 COMPLEXED WITH A QUINAZOLINE INHIBITOR
3DTCA:136-224CRYSTAL STRUCTURE OF MIXED-LINEAGE KINASE MLK1 COMPLEXED WITH COMPOUND 16
3DTWB:820-918; A:818-918CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A BENZISOXAZOLE INHIBITOR
3E3BX:26-116CRYSTAL STRUCTURE OF CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2ALPHA PRIME WITH A POTENT INDAZOLE-DERIVATIVE INHIBITOR
3E62A:839-931FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS
3E63A:840-931FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS
3E64A:839-931FRAGMENT BASED DISCOVERY OF JAK-2 INHIBITORS
3E7OB:10-112; A:10-112CRYSTAL STRUCTURE OF JNK2
3E87A:146-235,A:430-473; B:146-235,B:430-473CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP-COMPETITIVE INHIBITORS
3E88A:146-235,A:430-473; B:146-235,B:430-473CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP-COMPETITIVE INHIBITORS
3E8DA:146-235,A:430-473; B:146-235,B:430-473CRYSTAL STRUCTURES OF THE KINASE DOMAIN OF AKT2 IN COMPLEX WITH ATP-COMPETITIVE INHIBITORS
3E92A:3-110,A:320-349CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIARYL AMIDE INHIBITOR
3E93A:4-110,A:320-349CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIARYL AMIDE INHIBITOR
3EFJA:1061-1159; B:1061-1159STRUCTURE OF C-MET WITH PYRIMIDONE INHIBITOR 7
3EFKB:1061-1159; A:1061-1159STRUCTURE OF C-MET WITH PYRIMIDONE INHIBITOR 50
3EFWA:126-216; B:126-216STRUCTURE OF AURORAA WITH PYRIDYL-PYRIMIDINE UREA INHIBITOR
3EH9A:15-105CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE COMPLEXED WITH ADP
3EHAA:15-105CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE COMPLEXED WITH AMPPNP
3EIDA:1-84; C:1-84CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
3EJ1A:1-84; C:1-84CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
3EKKA:980-1078INSULIN RECEPTOR KINASE COMPLEXED WITH AN INHIBITOR
3EKNA:984-1078INSULIN RECEPTOR KINASE COMPLEXED WITH AN INHIBITOR
3ELJA:7-112JNK1 COMPLEXED WITH A BIS-ANILINO-PYRROLOPYRIMIDINE INHIBITOR.
3EQBA:61-146X-RAY STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) IN A COMPLEX WITH LIGAND AND MGATP
3EQPA:117-207; B:117-207CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T95
3EQRB:117-207; A:117-207CRYSTAL STRUCTURE OF ACK1 WITH COMPOUND T74
3ET7A:419-504CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-2318841
3ETAA:990-1078; B:990-1078KINASE DOMAIN OF INSULIN RECEPTOR COMPLEXED WITH A PYRROLO PYRIDINE INHIBITOR
3EYGA:865-958CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES
3EYHA:865-958CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES
3EZRA:1-84CDK-2 WITH INDAZOLE INHIBITOR 17 BOUND AT ITS ACTIVE SITE
3EZVA:1-84CDK-2 WITH INDAZOLE INHIBITOR 9 BOUND AT ITS ACTIVE SITE
3F2AA:32-124CRYSTAL STRUCTURE OF HUMAN PIM-1 IN COMPLEX WITH DAPPA
3F5GA:15-105CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE IN COMPLEX WITH ADP AND MG2+
3F5PA:980-1078; B:980-1078; C:980-1078; D:980-1078; E:980-1078; F:980-1078; G:980-1078; H:980-1078; I:980-1078; J:980-1078; K:980-1078; L:980-1078; M:980-1078; R:980-1078; S:980-1078; T:980-1078COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND 3-CYANOQUINOLINE INHIBITOR
3F5UA:15-105CRYSTAL STRUCTURE OF THE DEATH ASSOCIATED PROTEIN KINASE IN COMPLEX WITH AMPPNP AND MG2+
3F5XA:1-84; C:1-84CDK-2-CYCLIN COMPLEX WITH INDAZOLE INHIBITOR 9 BOUND AT ITS ACTIVE SITE
3F66B:1062-1159; A:1052-1159HUMAN C-MET KINASE IN COMPLEX WITH QUINOXALINE INHIBITOR
3F7ZA:53-136; B:53-136X-RAY CO-CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3BETA IN COMPLEX WITH AN INHIBITOR
3F82A:1061-1159CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH N-(4-(2-AMINO-3-CHLOROPYRIDIN-4-YLOXY)-3-FLUOROPHENYL)-4-ETHOXY-1-(4-FLUOROPHENYL)-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE
3F88A:53-136; B:53-136GLYCOGEN SYNTHASE KINASE 3BETA INHIBITOR COMPLEX
3FC2A:48-136PLK1 IN COMPLEX WITH BI6727
3FDNA:128-216STRUCTURE-BASED DRUG DESIGN OF NOVEL AURORA KINASE A INHIBITORS: STRUCTURE BASIS FOR POTENCY AND SPECIFICITY
3FE3A:50-134; B:50-134CRYSTAL STRUCTURE OF THE KINASE MARK3/PAR-1: T211A-S215A DOUBLE MUTANT
3FHRA:39-120HIGH RESOLUTION CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3 (MK3)-INHIBITOR COMPLEX
3FI2A:48-150CRYSTAL STRUCTURE OF JNK3 WITH AMINO-PYRAZOLE INHIBITOR, SR-3451
3FI3A:48-150CRYSTAL STRUCTURE OF JNK3 WITH INDAZOLE INHIBITOR, SR-3737
3FI4A:4-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO4499
3FKLA:4-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO9552
3FKNA:4-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO7125
3FKOA:5-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO3668
3FL4A:4-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO5634
3FLNC:3-110,C:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH R1487
3FLQA:4-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-2-((S)-2-METHANESULFONYL-1-METHYL-ETHYLAMINO)-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN
3FLSA:4-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-2-((R)-2-METHANESULFONYL-1-METHYL-ETHYLAMINO)-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3FLWA:4-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH PAMAPIMOD
3FLYA:4-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-2-ISOPROPYLAMINO-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3FLZA:4-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 8-METHYL-6-PHENOXY-2-(TETRAHYDRO-PYRAN-4-YLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3FMEA:46-132CRYSTAL STRUCTURE OF HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 6 (MEK6) ACTIVATED MUTANT (S207D, T211D)
3FMHA:4-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-8-METHYL-2-((R)-1-METHYL-2-TETRAZOL-2-YL-ETHYLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3FMJA:4-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 4-(5-METHYL-3-PHENYL-ISOXAZOL-4-YL)-PYRIMIDIN-2-YLAMINE
3FMKA:4-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-8-METHYL-2-((S)-1-METHYL-2-TETRAZOL-2-YL-ETHYLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
3FMLA:4-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO6224
3FMMA:4-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO6226
3FMNA:4-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO2530
3FPMA:59-140CRYSTAL STRUCTURE OF A SQUARATE INHIBITOR BOUND TO MAPKAP KINASE-2
3FQEA:363-450CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH YM193306
3FQHB:363-450; A:363-450CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH A 2-SUBSTITUTED 7-AZAINDOLE
3FQSA:363-450CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH R406
3FSFA:5-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 3-(2,6-DICHLORO-PHENYL)-7-[4-(2-DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-1-METHYL-3,4-DIHYDRO-1H-PYRIMIDO[4,5-D]PYRIMIDIN-2-ONE
3FSKA:5-110,A:320-349P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO6257
3FUPB:840-931; A:843-931CRYSTAL STRUCTURES OF JAK1 AND JAK2 INHIBITOR COMPLEXES
3FV8A:48-150JNK3 BOUND TO PIPERAZINE AMIDE INHIBITOR, SR2774.
3FWQA:25-115; B:25-115INACTIVE CONFORMATION OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT
3FXWA:39-120HIGH RESOLUTION CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3/INHIBITOR 2 COMPLEX
3FXXA:606-702HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION BOUND TO SUBSTRATE KQWDNYE[PTYR]IW
3FY2A:607-703HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION BOUND TO SUBSTRATE KQWDNYEFIW
3FYJX:59-140CRYSTAL STRUCTURE OF AN OPTIMZIED BENZOTHIOPHENE INHIBITOR BOUND TO MAPKAP KINASE-2 (MK-2)
3FYKX:59-140CRYSTAL STRUCTURE OF A BENZTHIOPHENE LEAD BOUND TO MAPKAP KINASE-2 (MK-2)
3FZ1A:1-84CRYSTAL STRUCTURE OF A BENZTHIOPHENE INHIBITOR BOUND TO HUMAN CYCLIN-DEPENDENT KINASE-2 (CDK-2)
3FZOA:420-504CRYSTAL STRUCTURE OF PYK2-APO, PROLINE-RICH TYROSINE KINASE
3FZPA:419-504CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH ATPGS
3FZRA:419-504CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-431396
3FZSA:420-504CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH BIRB796
3FZTA:420-504CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-4618433
3G0EA:542-672KIT KINASE DOMAIN IN COMPLEX WITH SUNITINIB
3G0FA:577-672; B:577-672KIT KINASE DOMAIN MUTANT D816H IN COMPLEX WITH SUNITINIB
3G33A:10-102; C:10-102CRYSTAL STRUCTURE OF CDK4/CYCLIN D3
3G90X:48-150JNK-3 BOUND TO (Z)-5-FLUORO-1-((6-FLUORO-4H-BENZO[D][1,3]DIOXIN-8-YL) METHYL)-3-(HYDROXYIMINO)INDOLIN-2-ONE
3G9LX:48-150JNK3 BOUND TO (Z)-1-((6-FLUORO-4H-BENZO[D][1,3]DIOXIN-8-YL)METHYL)-3-(HYDROXYIMINO)-4-STYRYLINDOLIN-2-ONE
3G9NA:4-106JNK3 BOUND TO (Z)-1-((6-FLUORO-4H-BENZO[D][1,3]DIOXIN-8-YL)METHYL)-3-(HYDROXYIMINO)-4-PHENYLINDOLIN-2-ONE
3GB2A:53-136GSK3BETA INHIBITOR COMPLEX
3GC7A:5-110,A:320-349THE STRUCTURE OF P38ALPHA IN COMPLEX WITH A DIHYDROQUINAZOLINONE
3GC8A:5-110,A:320-349; B:5-110,B:320-349THE STRUCTURE OF P38BETA C162S IN COMPLEX WITH A DIHYDROQUINAZOLINONE
3GC9A:5-110,A:320-348; B:5-110,B:320-349THE STRUCTURE OF P38BETA C119S, C162S IN COMPLEX WITH A DIHYDROQUINAZOLINONE INHIBITOR
3GCPA:18-110HUMAN P38 MAP KINASE IN COMPLEX WITH SB203580
3GCQA:18-110HUMAN P38 MAP KINASE IN COMPLEX WITH RL45
3GCSA:18-110HUMAN P38 MAP KINASE IN COMPLEX WITH SORAFENIB
3GCUA:18-110; B:18-110HUMAN P38 MAP KINASE IN COMPLEX WITH RL48
3GCVA:18-110HUMAN P38 MAP KINASE IN COMPLEX WITH RL62
3GENA:392-476THE 1.6 A CRYSTAL STRUCTURE OF HUMAN BRUTON'S TYROSINE KINASE BOUND TO A PYRROLOPYRIMIDINE-CONTAINING COMPOUND
3GFEA:5-110,A:320-349CRYSTAL STRUCTURE OF P38A MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH A PYRAZOLOPYRIDINONE INHIBITOR
3GI3A:18-110CRYSTAL STRUCTURE OF A N-PHENYL-N'-NAPHTHYLUREA ANALOG IN COMPLEX WITH P38 MAP KINASE
3GOKA:59-140; B:59-140; C:59-140; D:59-140; E:59-140; F:59-140; G:59-140; H:59-140; I:59-140; J:59-140; K:59-140; L:59-140BINDING SITE MAPPING OF PROTEIN LIGANDS
3GP0A:5-110,A:320-348CRYSTAL STRUCTURE OF HUMAN MITOGEN ACTIVATED PROTEIN KINASE 11 (P38 BETA) IN COMPLEX WITH NILOTINIB
3GQIA:465-563CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
3GQLA:465-563; B:465-563; C:465-563CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES
3GXLA:1-84ALK-5 KINASE COMPLEX WITH GW857175
3H0YA:128-216AURORA A IN COMPLEX WITH A BISANILINOPYRIMIDINE
3H0ZC:128-216; B:128-216; A:128-216AURORA A IN COMPLEX WITH A BISANILINOPYRIMIDINE
3H10A:128-216; B:128-216; D:128-216AURORA A INHIBITOR COMPLEX
3H30A:25-115; B:25-115CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF HUMAN PROTEIN KINASE CK2 WITH 5,6-DICHLORO-1-BETA-D-RIBOFURANOSYLBENZIMIDAZOLE
3H9OA:75-165PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK-1) IN COMPLEX WITH COMPOUND 9
3H9RA:172-287CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF TYPE I ACTIVIN RECEPTOR (ACVR1) IN COMPLEX WITH FKBP12 AND DORSOMORPHIN
3HA6A:128-216CRYSTAL STRUCTURE OF AURORA A IN COMPLEX WITH TPX2 AND COMPOUND 10
3HA8A:5-110,A:320-349THE COMPLEX STRUCTURE OF THE MAP KINASE P38/COMPOUND 14B
3HDMA:88-182CRYSTAL STRUCTURE OF SERUM AND GLUCOCORTICOID-REGULATED KINASE 1 IN COMPLEX WITH COMPOUND 1
3HDNA:88-182CRYSTAL STRUCTURE OF SERUM AND GLUCOCORTICOID-REGULATED KINASE 1 IN COMPLEX WITH COMPOUND 2
3HECA:18-110P38 IN COMPLEX WITH IMATINIB
3HEGA:18-110P38 IN COMPLEX WITH SORAFENIB
3HL7A:17-109CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH SD-0006
3HLLA:18-110CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH PH-797804
3HMMA:1-84STRUCTURE OF ALK5 + GW855857
3HNGA:803-911CRYSTAL STRUCTURE OF VEGFR1 IN COMPLEX WITH N-(4-CHLOROPHENYL)-2-((PYRIDIN-4-YLMETHYL)AMINO)BENZAMIDE
3HP2A:18-110CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A PYRIDINONE COMPOUND
3HP5A:18-110CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A PYRIMIDOPYRIDAZINONE COMPOUND
3HRBA:18-110P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3HRCA:76-165CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH ATP
3HUBA:18-110HUMAN P38 MAP KINASE IN COMPLEX WITH SCIOS-469
3HUCA:18-110HUMAN P38 MAP KINASE IN COMPLEX WITH RL40
3HV3A:18-110HUMAN P38 MAP KINASE IN COMPLEX WITH RL49
3HV4A:18-110; B:18-110HUMAN P38 MAP KINASE IN COMPLEX WITH RL51
3HV5A:18-110; B:18-110HUMAN P38 MAP KINASE IN COMPLEX WITH RL24
3HV6A:18-110HUMAN P38 MAP KINASE IN COMPLEX WITH RL39
3HV7A:18-110HUMAN P38 MAP KINASE IN COMPLEX WITH RL38
3HVCA:18-110CRYSTAL STRUCTURE OF HUMAN P38ALPHA MAP KINASE
3I4BB:53-136; A:55-136CRYSTAL STRUCTURE OF GSK3B IN COMPLEX WITH A PYRIMIDYLPYRROLE INHIBITOR
3I5NA:1052-1159CRYSTAL STRUCTURE OF C-MET WITH TRIAZOLOPYRIDAZINE INHIBITOR 13
3I5ZA:6-105,A:337-354CRYSTAL STRUCTURE OF ERK2 BOUND TO (S)-N-(2-HYDROXY-1-PHENYLETHYL)-4-(5-METHYL-2-(PHENYLAMINO)PYRIMIDIN-4-YL)-1H-PYRROLE-2-CARBOXAMIDE
3I60A:6-105,A:337-354CRYSTAL STRUCTURE OF ERK2 BOUND TO (S)-4-(2-(2-CHLOROPHENYLAMINO)-5-METHYLPYRIMIDIN-4-YL)-N-(2-HYDROXY-1-PHENYLETHYL)-1H-PYRROLE-2-CARBOXAMIDE
3I81A:955-1048CRYSTAL STRUCTURE OF INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF-1R-WT) COMPLEX WITH BMS-754807 [1-(4-((5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO)PYRROLO[2,1-F][1,2,4]TRIAZIN-2-YL)-N-(6-FLUORO-3-PYRIDINYL)-2-METHYL-L-PROLINAMIDE]
3IDPA:449-533; B:449-533B-RAF V600E KINASE DOMAIN IN COMPLEX WITH AN AMINOISOQUINOLINE INHIBITOR
3IG7A:1-84NOVEL CDK-5 INHIBITORS - CRYSTAL STRUCTURE OF INHIBITOR EFP WITH CDK-2
3IGGA:1-84NOVEL CDK-5 INHIBITORS - CRYSTAL STRUCTURE OF INHIBITOR EFQ WITH CDK-2
3II5A:447-532; B:448-532THE COMPLEX OF WILD-TYPE B-RAF WITH PYRAZOLO PYRIMIDINE INHIBITOR
3IO7A:842-9312-AMINOPYRAZOLO[1,5-A]PYRIMIDINES AS POTENT AND SELECTIVE INHIBITORS OF JAK2
3IOKA:842-9312-AMINOPYRAZOLO[1,5-A]PYRIMIDINES AS POTENT AND SELECTIVE INHIBITORS OF JAK2
3IONA:75-165PDK1 IN COMPLEX WITH COMPOUND 8H
3IOPA:75-165PDK-1 IN COMPLEX WITH THE INHIBITOR COMPOUND-8I
3IPHA:18-110CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH A BIPHENYLAMIDE INHIBITOR
3ITZA:-3-110,A:320-349CRYSTAL STRUCTURE OF P38A MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH A PYRAZOLOPYRIDAZINE INHIBITOR
3IW4B:332-423,B:618-656; A:331-423,A:618-656; C:330-423,C:618-656CRYSTAL STRUCTURE OF PKC ALPHA IN COMPLEX WITH NVP-AEB071
3IW5A:18-110HUMAN P38 MAP KINASE IN COMPLEX WITH AN INDOLE DERIVATIVE
3IW6A:18-110HUMAN P38 MAP KINASE IN COMPLEX WITH A BENZYLPIPERAZIN-PYRROL
3IW7A:18-110HUMAN P38 MAP KINASE IN COMPLEX WITH AN IMIDAZO-PYRIDINE
3IW8A:18-110STRUCTURE OF INACTIVE HUMAN P38 MAP KINASE IN COMPLEX WITH A THIAZOLE-UREA
3JPVA:33-124CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A PYRROLO[2,3-A]CARBAZOLE LIGAND
3JS2A:465-563; B:465-563CRYSTAL STRUCTURE OF MINIMAL KINASE DOMAIN OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH 5-(2-THIENYL) NICOTINIC ACID
3JUHA:25-115; B:25-115CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PROTEIN KINASE CK2ALPHA WITH ALTERED COSUBSTRATE SPECIFICITY
3JXWA:33-124DISCOVERY OF 3H-BENZO[4,5]THIENO[3,2-D]PYRIMIDIN-4-ONES AS POTENT, HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS
3JY0A:33-124DISCOVERY OF 3H-BENZO[4,5]THIENO[3,2-D]PYRIMIDIN-4-ONES AS POTENT, HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS
3JY9A:842-931JANUS KINASE 2 INHIBITORS
3JYAA:33-124DISCOVERY OF 3H-BENZO[4,5]THIENO[3,2-D]PYRIMIDIN-4-ONES AS POTENT, HIGHLY SELECTIVE AND ORALLY BIOAVAILABLE PIM KINASES INHIBITORS
3K3IA:18-110P38ALPHA BOUND TO NOVEL DGF-OUT COMPOUND PF-00215955
3K3JA:18-110P38ALPHA BOUND TO NOVEL DFG-OUT COMPOUND PF-00416121
3KA0A:59-140MK2 COMPLEX WITH INHIBITOR 6-(5-(2-AMINOPYRIMIDIN-4-YLAMINO)-2-HYDROXYPHENYL)-N-METHYLBENZO[B]THIOPHENE-2-CARBOXAMIDE
3KB7A:48-136CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR
3KC3A:59-140; B:59-140; C:59-140; D:59-140; E:59-140; F:59-140; G:59-140; H:59-140; I:59-140; J:59-140; K:59-140; L:59-140MK2 COMPLEXED TO INHIBITOR N4-(7-(BENZOFURAN-2-YL)-1H-INDAZOL-5-YL) PYRIMIDINE-2,4-DIAMINE
3KCFA:171-284; B:171-284; C:171-284; D:171-284; E:171-284CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR
3KCKA:842-931A NOVEL CHEMOTYPE OF KINASE INHIBITORS
3KF7A:18-110CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A TRIAZOLOPYRIMIDINE COMPOUND
3KGAA:59-140CRYSTAL STRUCTURE OF MAPKAP KINASE 2 (MK2) COMPLEXED WITH A POTENT 3-AMINOPYRAZOLE ATP SITE INHIBITOR
3KQ7A:5-110,A:320-349STRUCTURE OF HUMAN P38ALPHA WITH N-[4-METHYL-3-(6-{[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]AMINO}PYRIDINE-3-AMIDO)PHENYL]-2-(MORPHOLIN-4-YL)PYRIDINE-4-CARBOXAMIDE
3KRWA:186-275,A:495-512HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (SOAK)
3KRXA:186-275,A:495-512HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (CO-CRYSTAL)
3KULA:627-715; B:627-715KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 8 (EPHA8)
3KVXA:48-150JNK3 BOUND TO AMINOPYRIMIDINE INHIBITOR, SR-3562
3KXXA:465-563; B:465-563; C:465-563; D:465-563STRUCTURE OF THE MUTANT FIBROBLAST GROWTH FACTOR RECEPTOR 1
3KY2A:465-563; B:465-563CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE DOMAIN
3L1SB:53-136; A:55-1363-ARYL-4-(ARYLHYDRAZONO)-1H-PYRAZOL-5-ONES: HIGHLY LIGAND EFFICIENT AND POTENT INHIBITORS OF GSK3
3L8SA:18-110HUMAN P38 MAP KINASE IN COMPLEX WITH CP-547632
3L8VA:1061-1159CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITH A BIARYLAMINE BASED INHIBITOR
3L8XA:4-110,A:320-349P38 ALPHA KINASE COMPLEXED WITH A PYRAZOLO-PYRIMIDINE BASED INHIBITOR
3LAUA:128-216CRYSTAL STRUCTURE OF AURORA2 KINASE IN COMPLEX WITH A GSK3BETA INHIBITOR
3LB7  [entry was replaced by entry 3OMV without any CATH domain information]
3LCDA:563-665INHIBITOR BOUND TO A DFG-IN STRUCTURE OF THE KINASE DOMAIN OF CSF-1R
3LCKA:231-318THE KINASE DOMAIN OF HUMAN LYMPHOCYTE KINASE (LCK), ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394)
3LFNA:1-84CRYSTAL STRUCTURE OF CDK2 WITH SAR57, AN AMINOINDAZOLE TYPE INHIBITOR
3LFQA:1-84CRYSTAL STRUCTURE OF CDK2 WITH SAR60, AN AMINOINDAZOLE TYPE INHIBITOR
3LFSA:1-84CRYSTAL STRUCTURE OF CDK2 WITH SAR37, AN AMINOINDAZOLE TYPE INHIBITOR